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Abstract
The use of nanoparticles (NPs) for radiation dose enhancement is an ever-growing
field that is founded upon the idea that high-Z nanoparticles will enhance radiation
dose to cancer tissue. Introducing a novel approach to this concept with silverdoped Lanthanum Manganite (LAGMO) at silver doping’s of 0, 2.5, 5 & 10% is
both daunting and promising due to previous success witnessed with other NP’s
such as gold. The combination of nanoparticles and radiation necessitates a full
characterisation of interaction, response and toxicity to both healthy and cancer
cell lines. An understanding of these factors was achieved through monitoring the
cell condition and growth of 9L Gliosarcoma (9LGS) brain cancer cells in comparison
to Madin-Darby Canine Kidney (MDCK) cells.
The response of both cancer and healthy cell lines to the LAGMO NPs at 50
µg/mL revealed that there was a completely cancer-selective toxic response at 0%,
2.5% and 5% silver doping, while 10%-LAGMO NPs were toxic to both. The toxicity
to 9LGS was attributed to a significant increase in total Reactive Oxygen Species
(ROS), which became amplified at 2.5% and 5% silver doping. 10%-LAGMO NPs,
however, showed a drop-off in total ROS for 9LGS and a sharp increase for MDCK
in comparison to the other NP’s. As a result of the 2.5% and 5%-LAGMO NPs
producing significantly higher levels of ROS within the cancer cell line and 10%LAGMO NPs being toxic to both cell lines, it was concluded that 0%-LAGMO NPs
were most appropriate for experimentation as a multimodal treatment combined
with radiation therapy.
The interaction of radiation with NPs on each cell line was evaluated by monitoring growth and repairability. 9LGS exposure to 125 kVp orthovoltage radiation
at 2 Gy after 24 hours incubation with 20 µg/mL of 0%-LAGMO NPs hindered its
growth but eventually recovered, while 8 Gy completely destroyed the cells ability
to grow. Growth in the case of NP pre-treated MDCK cells prior to irradiation,
was boosted, which suggests that the NPs were protecting the healthy cell line from
radiation damage. Not only does this substantiate the cancer cell selectivity of 0%LAGMO NPs alongside radiation, but it also highlights the potential for it to prevent
damage to healthy cells surrounding cancer tissue in a clinical situation. Chemical
toxicity seemingly dominates the reactions taking place with radiation and 9LGS,
iii
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superseding the effect of dose enhancement at a low dose combined with relatively
low NP concentration.
9LGS irradiated with 125 kVp orthovoltage radiation after incubation for 24
hours with 50 µg/mL presents a surviving fraction of (3.7 ± 11.5)% at 0 Gy and
(0.6 ± 6.7)% at 2 Gy. Therefore, challenging the idea of radiation dose enhancement
through the production of secondary electrons, as it is over-powered by the NPs’ explicit potency to the cell line. Lastly, radiation in combination with the NPs heavily
impacted its growth and repairability and at high doses, completely eliminates its
ability to do so.

KEYWORDS: Radiotherapy, orthovoltage radiation, nanoparticle, lanthanum
manganite, selectivity
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Chapter 1
Introduction
Cancer is a relentless life-threatening disease that affects men and women of all ages
[1]. In addition to this, glioblastoma, the most aggressive variant of brain cancer,
has both the highest diagnostic rate and lowest 5-year survival rate of all brain and
central nervous system cancers (see Figure 1.1) [1, 2, 3]. These facts are indicative
of the lack of curative treatment to areas such as the brain, highlighting simply
that improvements to treatment techniques are vital. Shining a light on some of
the less focused realities of tumours like gliomas is the effect it has on the patients’
quality of life. Some of the quality of life parameters that are heavily affected by
tumours in general include, motor function, social interactions, seizures, fatigue and
mild aphasia (loss of speech) [4, 5]. Specifically pertaining gliomas, the tumour and
treatments’ secondary effects have been found to cause a significantly worse quality
of life in all areas compared to many other cancers [4, 6]. More focus needs to be
placed on targeted treatment to tumours that originate in the brain in order to not
only improve treatment but to change the stigma that is placed on the term ’brain
cancer’.
Most treatment of brain gliomas are performed using a combination of surgery
and radiotherapy together with chemotherapy, which not only has extreme side
effects to the patient but also increases the price of treatment approximately 9fold [7]. Radiotherapy is used in conjunction with other treatment modalities since
the application of external radiation alone on radioresistant tumours such as those
originating in the brain, fails to cause enough damage to the DNA of cancer cells
while keeping the damages to surrounding healthy tissues to an acceptable level.
Therefore, it has become imperative to significantly improve the cancer treatment
technique through increasing the impact of radiation at the tumour site. Radiation
dose enhancement has been successful in many forms of cancer through the use of
high atomic number (Z) nanoparticles (NPs) such as gold and gadolinium. The
clinical investigation of gold NPs is still relatively new with current active studies
underway on small patient groups, while gadolinium is a current MRI contrast agent.
3
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However, gold NPs are expensive and gadolinium has been known to have fatal
consequences when linked to nephrogenic systemic fibrosis [8, 9].

Figure 1.1: Number of new cases and 5-year survival rates of different brain
cancers, in men, women and all persons. Taken from [10]

The improvement in the industry, therefore, requires novel nanoparticles justified through its potential to act as imaging contrast agents and radiation dose
enhancers. The fundamental principle of high-Z dose enhancement due to photon interaction with matter relies on the large dependency of photon energy and
atomic number [11]. Photon interactions, such as the photoelectric effect, presents
a great deal of importance due to its strong dependence on Z for photon energies in
the kilovoltage range. Incoming photons in this range produce secondary electrons
in the form of auger electrons and compton scattering, capable of causing enough
damage to kill cancer cells. This concept, however, is limited to the actual cell to
nanoparticle interactions with regards to toxicity and internalisation.
The ability for a nanoparticle to enhance the contrast of an image as well as
enhance radiation dose has become of extreme importance. NPs which exhibit both
qualities, will allow a tracking of the nanoparticle, showing accumulation in the
tumour over time and therefore, guide treatment. In addition to this, it will also
improve the level of accuracy of the treatment planning involved when mapping out
the tumour for radiation exposure. Although there are many contrast agents that
are implemented clinically, it still remains a unique attribute for the contrast agent
to also have the potential to improve the impact of radiation and therefore, must
be pursued [12].
The study of the novel high-Z nanomaterial Lanthanum Manganite alongside
radiotherapy makes the revolution of a stagnant industry very promising. Outside
of radiation dose enhancement, the nanoparticle is currently being investigated for
its ability to induce hyperthermia to cells and also for its detectability via Magnetic
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Resonance Imaging (MRI) [13].

1.1

Aims & Methods

Bringing the two fields of nanoparticles and radiotherapy together requires a cohesive characterisation of their impact on a cancer cell line and also a healthy cell line.
The use of infamously radioresistant cancer cell 9L Gliosarcoma (9LGS) compared
directly against healthy cell MDCK will tackle issues involving cancer cell selectivity
and cancer killing ability both with and without radiation after nanoparticle treatment. This will be achieved through careful analysis on cell condition and growth
using MTT viability assays, monitoring the cells using the IncuCyte and fluorescent
microscope and investigating survival capabilities after exposure to radiation with
clonogenic assays and IncuCyte techniques.
The main aims of this thesis will be to characterise the toxicity of un-doped
Lanthanum Manganite to both cell lines. The study will also focus on the effect of
adding silver ions to the structure of the Lanthanum Manganite NPs. It will further
aim to indicate the nanoparticle with most potential alongside radiation therapy for
dose enhancement.

Chapter 2
Literature Review
This chapter begins with a background of the physical phenomenon that are fundamental to nanoparticle dose enhancement (section 2.1). This follows with a review
of the literature on the following topics: Nanoparticles in Radiation Therapy (section 2.2), a discussion of the successes and limitations of previous nanoparticles
that lead to this thesis; Nanoparticle Tumour Targeting (section 2.3), an evaluation of the parameters that control the ability to target tumours with nanoparticles;
Cellular Response to Radiation (Section 2.4), a general and specific analysis of 9L
Gliosarcoma cancer cell response to radiation.

2.1

The Physics of High-Z Dose Enhancement

Radiation upon impact of a material can result in the production of several phenomenon, the main ones being; the photoelectric effect, pair production and Compton scattering [11, 14, 15, 16]. All of these processes occur due to the way an atom
interacts with incoming radiation, where the corresponding dominance of one phenomenon is dependent on the photon energy of the radiation source and the atomic
number (Z) of the absorbing material (see Figure 2.1).

2.1.1

Radiation Interaction with a High-Z Material

The photoelectric effect is a phenomenon that occurs when an atom absorbs all of an
incoming photons’ energy and an electron is ejected from its corresponding atom.
This leaves a vacancy which must be replaced, and thus an outer shell electron
will fill the gap, but in doing so, must give off a characteristic x-ray [11]. If this
characteristic x-ray is re-absorbed inside the atom, a new electron vacancy will be
created, producing a cascade of low-energy Auger electrons. These electrons possess
the ability to release energy onto its surroundings known as the linear energy transfer (LET), for approximately 10 nm, delivering at a high local ionisation density
6
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Figure 2.1: Diagram illustrating the predominance of photon-matter interactions with atomic number and photon energy.

[14]. The production of secondary particles such as Auger electrons is very useful
in specific targeting where distance to the nucleus of cells is minimal. The killing
of cancer cells via irradiation is caused by targeting the DNA of a cell, both directly and indirectly. In the case that molecules binding the DNA become damaged
from the radiation and is able to cause both strands to break, labelled a double
strand break (DSB), the cancer cell would not survive. However, due to the nature
of most cancers, survival of cells after irradiation occurs due to the fact that not
enough damage is dealt. This ultimately results in only single strand breaks (SSBs),
where one strand of a DNA molecule is broken, and therefore, are able to recover.
Specifically, for radioresistant 9LGS, survival at 8 Gy is approximately 18%, which
indicates that even relatively high doses of radiation are unable to kill the cancer
cells. By producing more secondary electrons due to high-Z nanoparticle (NP) interaction with radiation inside or near cancer cells at a tumour site, there is a greater
possibility to achieve DSBs and thus increase cell death at the same dose compared
to without nanoparticles [17].
Z3
The photoelectric absorption atomic cross section varies according to E
3 , where
Z is the atomic number of target material and E is the photon energy. In the
case that the photoelectric effect is the most desirable radiation interaction with
a material, low energy photons, such as those used to treat cancers in the orthovoltage range (100-500 keV), have an advantage over other techniques. Common
techniques employed to target cancer involves the usage of megavoltage (MV) radiation produced by a linear accelerator. However, in order to capitalise on the
increased probability of the photoelectric effect, high-Z NPs are used in conjunction
with orthovoltage radiation. This is also aided with the NPs ability to enter the
vasculature of a tumour (described in Section 2.3) and create a localised increased
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Figure 2.2: Electron range in water at different photon energies. Taken from
Hainfeld et. al. [18].

energy deposition (see Figure 2.2) [11, 15, 16].
Although the photoelectric effect predominates when delivering orthovoltage
radiation, deliberation of the compton effect is important. The compton effect
occurs when photons interact with a loosely bound electron in the outer shell of an
atom, causing the electron to eject and the photon to be incoherently scattered at
an angle with a reduced energy. As it relies on the electron density, the significant
increase of this value in hydrogenous materials in comparison to anhydrogenous
materials causes this effect to mainly occur in tissue [14, 15, 16].
Lastly, pair production is an interaction that can occur when the energy of an
imparting photon on an atom exceeds 1.02 MeV, which is twice the rest mass of
an electron, and thus producing an electron-positron pair. Since orthovoltage xrays do not reach this energy, it will not be an occurrence and does not need to
be considered for this study [15, 16, 18]. The effect of pair production will be very
useful at the energies utilised in MV radiotherapy and will make a contribution when
MV radiation is used with high-Z NPs.

2.1.2

Optimal Irradiation Energy

The consideration of photon energy is of the greatest importance as it will determine
which physical phenomenon will be most predominant. Using high-Z lanthanum
Manganite NPs with orthovoltage radiation to treat 9L gliosarcoma (9LGS) cancer
cells is most promising as it will utilise the significant production of secondary particles through the photoelectric effect. In determining the most appropriate energy
range that will target the NP, an important parameter that must be considered is
the mass-energy absorption coefficient. It’s defined as the fraction of the photons’

CHAPTER 2. LITERATURE REVIEW

9

energy multiplied by the mass attenuation coefficient, which is a unit that represents how much of the photon attenuates through the material [10]. Therefore, when
the mass-energy absorption coefficient is large, a large amount of energy is being
absorbed by the atom and transferred to the kinetic energy of ejected secondary
particles.

Figure 2.3: Ratio of the mass-energy absorption coefficient of pure Lanthanum
Manganite to Water as a function of energy (the primary y-axis on the left). The
mass-energy absorption data for both materials was generated using XMuDat
software [19]. 125 kVp orthovoltage x-ray spectra as a function of energy (the
secondary y-axis on the right). The data for the 125 kVp spectra was retrieved
using SpekCalc [20].

The ratio of the mass-energy absorption coefficient of pure Lanthanum manganite to water is fundamental to the energy chosen for the photons in orthovoltage
radiation treatment (see Figure 2.3). It illustrates how much more photon absorption will occur in comparison to tissue and as mentioned earlier, will lead to the increased production of secondary electrons. The maximum value for the mass-energy
absorption coefficient ratio is 96.4 at 52 keV. The beam energy most appropriate
at utilising this large ratio is produced from 125 kVp x-rays as it has an effective
energy of 60.5 keV. Therefore, the mean energy of the photons as a result of this
x-ray beam will produce an almost maximum number of secondary particles at the
site of the NPs.

2.2

Nanoparticles in Radiation Therapy

Nanoparticles have become extremely resourceful materials creating advancements
in areas of construction, robotics, genomics and most importantly medicine [21].
Due to their extremely small size they provide overwhelming opportunity to deliver
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or enhance treatment at the cellular level. Particles are globally considered to be a
nanoparticle when it is within 0-100 nm in diameter/length and has endless possibilities in shape design that is specific to its function or composition. There have
been many successes in nanoparticle enhanced radiation therapy, which has seen
implementation in clinical situations. The choice of lanthanum manganite doped
with silver delivered to 9LGS cells is derived from these successes with the aim of
introducing a potential advantage over the use of clinically failing NPs such as gold
and gadolinium.

2.2.1

Magnetic Nanoparticles

Utilisation of the magnetic properties exhibited in nanoparticles introduces a multifunctional aspect to tumour targeting allowing for easy tracking into difficult regions
of the body such as the brain, which is often restricted due to the blood brain barrier (BBB). The BBB presents its difficulty through a tightly packed blood transfer
system from the spinal cord to the brains’ blood capillaries. A popular clinical
magnetic resonance imaging (MRI) contrast agent is Superparamagnetic Iron Oxide
Nanoparticles (SPIONs) and they are coined superparamagnetic because they display magnetic properties parallel to and under the influence of an external magnetic
field [13].
Theranostic technology is an extremely valuable addition to the application
of cancer treatments, possessing potential implementation and improvements on
drug delivery, phototherapy and radiotherapy [22]. MRI scanners utilise the large
amounts of hydrogen, which have one proton inside their atoms, throughout the
body in the form of water. When applying a magnetic field, these protons align
themselves and precess at a certain frequency around this magnetic field. At this
point a transverse Radiofrequency pulse (RF) is applied, and thus perturbs the
protons’ spin [23]. They ultimately return to their normal state through independent
relaxation periods (T1 and T2), however, these periods are characterised according
to the tissue being imaged [24]. T1-relaxation is the result of protons returning to
the normal position parallel to the static magnetic field. The speed at which it does
so will output a corresponding signal, with fast relaxation times correlating to a high
intensity signal. On the other hand, T2-relaxation times are due to the protons loss
of coherence when spins of each nuclei interact at random phases as a consequence
of the RF signal being a pulse [24].
The mechanism of MRI contrast agents involves the disruption of the proton
spins in the localised area around the contrast agent. This is attainable when
nanoparticles under investigation as a contrast agent has an affinity for the cells
in this localised imaging region, or the tissues that surround it differ in vascularity
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[24]. Since the nanoparticles can influence the magnetic moments of the protons,
T1 and T2 relaxation times can ultimately be reduced and therefore show a difference in contrast in the produced image. This is an extremely desirable quality as
it provides the opportunity to readily track the NPs accumulation with time in the
tumour for optimal radiation treatment. Specifically, for the case of silver doped
Lanthanum Manganite, Melnikov et. al. 2008, investigated LAGMO NPs with MRI
using two methods, one was injection straight into the mouse brain and the other
intravenously [13]. Both methods showed significant decreases in signal intensity at
the site of the NPs. This study also highlights the potential for the LAGMO NPs to
be used for radiation dose enhancement and image contrast improvements in vivo,
as there was a successful accumulation of NPs at the tumour site.

2.2.2

Gold Nanoparticles

The work of James F. Hainfeld, was fundamental to the success of gold nanoparticles and provided opportunity for nanoparticle implementation to radiation therapy
[14]. A series of short-term experiments were conducted on mice in order to investigate the dose enhancement when injected intravenously. The results of this research
displayed the concentration dependency of dose enhancement with 50% and 86%
one-year survival of a population at 1.35 gAu /kg and 2.7 gAu /kg concentration respectively [25]. This supports the theoretical assumption that the more NPs present
at the site, the better the cancer killing. Furthermore, this shows that concentration capabilities can be raised to high levels, which is an extremely desirable quality,
where dose enhancement depends highly on how many NP atoms are present at the
site. However, the point at which nanoparticles become toxic to cells due to high
concentrations of NPs is of major concern and must be defined explicitly.
A study conducted by Rahman et. al. investigated gold cytotoxicity on bovine
aortic endothelial cells by evaluating cell viability. Results showed that concentrations as high as 200 µg/mL only reduced viability to 75% with respect to cells
that received no gold NPs [26]. Although it seems non-cytotoxic concentration results are conclusive, it should also be considered that cytotoxicity may vary with
cell type [27]. Fittingly, there has been a large amount of research conducted on
gold nanoparticles, however an accumulation of conflicting results with regards to
tumour specificity, design and sensitization capability has affected its potential in
the clinical setting [28]. Currently, there are a number of clinical investigations still
underway attempting to justify its use for the treatment of cancer in humans [29].
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Hafnium Oxide

Hafnium oxide (Z=72) nanoparticles are potential NPs for radiation dose enhancement as they increase the energy deposited by radiation through their interaction.
The NPs have proceeded to Phase II-III trials for the treatment of locally advanced
soft-tissue sarcoma due to the success of many studies [30, 31]. A study conducted
by Marill et. al. on the NPs effect on various cancer cell lines including gliobastoma
assessed several parameters such as radiation dose enhancement and cellular uptake
[31]. The study concluded that the NP is biologically predictable in vitro when used
alongside radiation to target cancers, however, also noting that the NP does not
exactly function to sensitise the cells to radiaton damage [31]. Additionally, the
study found that the radiation dose enhancement factor at 2 Gy for radioresistant
cells ranged between 1 and 1.5, whereas radiosensitive cells ranged between 2 and 3
[31]. It is assumed that using this NP in conjunction with the treatment of 9LGS
could also have a similar result. As 9LGS is known to be an extremely radioresistant
cell line and can recover quite readily to radiation damage it is necessary that the
investigated nanoparticle not only has the ability to enhance the radiation dose to
the cancer but also has the ability to cause sensitisation through its function at the
cellular level.

2.2.4

Gadolinium Nanoparticles

Gadolinium is a rare earth element in the lanthanide series and has seen considerable
levels of success in radiosensitisation and most importantly as a MRI contrast agent.
It has catapulted a research field dedicated to making improvements in localisation
of nanoparticles readily tracked by MRI and can potentially improve the theranostic
treatment of radioresistant brain tumours. Studies of free gadolinium NPs began
with utilisation of synthetic porphyrin-like molecules, known as texaphryins, transporting both lanthanides and non-lanthanide metals [32, 33]. Phase I trials were
conducted using Gadolinium-texaphryin after studies revealed that it successfully
accumulates in the brain, induces DNA damage to cells and is an effective modulator
of tumour oxygenation [33, 34, 35].
Although gadolinium has seen success, it has certainly experienced some roadblock in its way through the theranostic industry with commercial contrast agents
showing a strong link to nephrogenic systemic fibrosis (NSF). NSF can cause severe
skin induration, which in some cases is very painful and has the potential to cause
physical disability [8]. Indeed, for any associated risk with a foreign material being
injected, precise classification is essential before application in Phase I clinical trials. An even more concerning issue for gadolinium lies within its ionic radius, as
it is similar to that of calcium ions. Therefore, the administration of gadolinium
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towards a tumour must be assessed extensively as it has the potential to inhibit calcium channels and can also replace calcium [22, 36]. The limitations of gadolinium
nanoparticles have encouraged the classification of other rare-earth elements in the
lanthanide series, such as Lanthanum, in order to provide an alternative treatment
technique with potential benefits over its controversial use.

2.2.5

Lanthanum Manganite

Iron oxide nanoparticles are excellent drugs in cancer therapy as they possess biocompatibility, chemically stability and excellent magnetic properties [37]. However,
due to their low atomic number, radiation dose enhancement is significantly reduced
and relatively insignificant compared to higher-Z materials.
The investigation of Lanthanum Manganite NPs in this thesis is proposed as an
alternative to super-paramagnetic iron oxide nanoparticles (SPIONs) but will attempt to introduce a radiation dose enhancement due to its relatively high effective
atomic number of 48. Lanthanum manganite is a recently studied nanoparticle and
is characterised as a rare earth manganite that is paramagnetic. It also possesses the
ability to adjust its Curie temperature according to the silver doping level [13] and
thus may provide major innovation in the field of hyperthermia-induced targeted
therapy. Additionally, a study conducted by Melnikov et. al. 2008, showed that
when doped with silver, the nanoparticles-maintained biocompatibility and were
detectable via MRI [13]. Although the study does state that the NPs were biocompatible, specific concentrations were not discussed. Therefore, it is unclear as to
whether there is high toxicity to cells exhibited by the NPs. It is also possible that
the silver positively charged ions present in the doped lanthanum manganite bind
to the negatively charged proteins such as DNA and RNA, and this may cause cell
replication to become excessively inhibited [39]. It is hypothesised that an increasing concentration of Lax Ag1−x MnO3 (LAGMO) NPs, will show significant increase
in toxicity to cells and must be characterised if it is to be implemented for radiation
dose enhancement or hyperthermia treatments. This may not be an issue, however,
as sufficient concentrations normally do not exceed a relatively achievable 50 µg/mL.
Thus, before cells are irradiated, an evaluation of cell death at this concentration is
necessary for characterisation.
An extremely valuable characteristic of LAGMO NPs is detectability via MRI
and this provides an advantageous usage in a wide variety of treatments. Furthermore, the research conducted in my thesis is an extension on the idea that the
magnetic properties of LaMnO3 within the cell is unaffected as specified by Melnikov et. al. 2008 [13]. In addition to its use as an MRI contrast agent, it may
also be investigated with CT imaging. CT contrast agents are highly dependent on
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their atomic number for contrast enhancement as the imaging modality relies on
measurements of x-ray absorption [40]. Lanthanum Manganite (Zef f = 48) can also
possibly be used as a CT contrast agent due to its ability to increase the production
of the photoelectric effect in the kilovoltage range used to image and thus, will have
greater absorption than the surrounding tissues.

2.2.6

Silver-Doped Nanoparticles

A major issue which restricts the use of silver-doped nanoparticles for cancer treatment, is its previous history of causing excessive toxicity to cells [41]. Moreover,
silver ions have been proven to produce free radicals, such as reactive oxygen species,
due to intracellular interactions and potentially doing so within 24 hours of exposure
to a cell [42, 43].
Specifically, in the case study presented by Ahamed et. al. 2017, silver-doped
Titanium Oxide (TiAgO2 ) NPs were synthesised using the sol-gel method and experimented with breast cancer cell line MCF-7, lung cancer cell line A549 and liver
cancer cell line HepG2 [44]. In the study, it was discovered that an increase in the
amount of silver doping would directly correlate to an increase in the cytotoxicity of
all cell lines [44]. Furthermore, this toxicity was found to be a direct consequence of
the induced oxidative stress and also an inhibited antioxidant defence for all types
of cells.
This is of particular importance as it may have benificial outcomes of cell death
if the NPs investigated in this thesis are cancer selective in their toxicity. There is
also a risk, however, that the NPs are toxic to both healthy and cancer cell lines,
although, in this situation the nanoparticles can potentially be coated in order to
slightly reduce their toxicity.

2.3

Nanoparticle Tumour Targeting

High-Z NPs, as described in section 2.2, are excellent absorbers of radiation and
have shown positive results when injected via tail-vein in mice [14]. The efficacy of
radiosensitisation, however, is dependent on a number of parametric properties of
the tumour and the NP itself. In addition to this, feasibility of applying gold or
any other high-Z NP to targeted therapy relies on the localisation of each particle
within the tumour [45]. The leaky networks of tumours formed by endothelium and
accompanied by the lack of an efficient lymphatic system allows NPs to conveniently
accumulate in the tumour and retain longer, relative to normal tissues [45-50]. The
enhanced permeation and retention (EPR) effect is responsible for the production
of these systems. However, this effect is not consistent with the many tumour
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models that an individual might attain, as some do not require extensive angiogenesis
for growth [38, 51, 52, 53]. Some carcinomas such as hepatocellular carcinoma
and colorectal carcinoma show an absence of adequate micro-vessels inhibiting the
passage of most incoming nanoparticles [51]. This is not the case for 9LGS as it is
well known that NPs are accessible to it through the EPR effect [54]. Furthermore,
due to the invasive nature of a 9LGS grade IV tumour, the BBB is disrupted and
does not impede NP intake [55].

2.3.1

Cellular Internalisation of Nanoparticles

Many biological factors of mammalian cells aid in allowing access to internalisation pathways for extracellular material, the main one being endocytosis [56, 57].
Endocytosis, which generalises a subset of pathways, phagocytosis and pinocytosis,
allows cancer cells such as 9LGS to invaginate nanoparticles from the extracellular
matrix it is assigned to. In the case of phagocytosis, nanoparticle internalisation
is often mediated through van der Waals, ionic, electrostatic and hydro-responsive
interactions with the nanoparticle surface and the cell membrane [57]. In addition to this, nanoparticles become more susceptible to internalisation if their surface
absorbs minerals from the medium they are presented to cells in, known as opsonisation. Nanoparticles can also be optimised to facilitate a macropinocytotic response,
where mirco-sized aggregates of NPs are internalised [57].
Another important internalisation pathway, once access to the tumour is achieved
with NPs, is through ligand-receptor interactions at the cellular level [54, 58, 59,
60]. In order to maximise the amount of internalised NPs for a treatment, ligands
can be attached to the surface of NPs, allowing action through this pathway. While
9LGS, fortunately, expresses many receptors on the surface of its cells, which include
EGFR, transferrin receptors (in most metastatic cell lines) and most importantly
folate receptors [53]. Ligands on the surfaces of nanoparticles selectively bind to
receptors and thus, experience invagination through the process of mediated endocytosis [61]. It is also important to note that most cancers exhibit an overexpression
of folate receptors and thus have a natural selectivity to NPs with ligands [62].
Figure 2.4, visualises this effect, and also shows why high-Z NP uptake will be advantageous if secondary electrons are produced inside a tumour cell. Houssain et.
al. 2012, simulated various distances between gold, bismuth and platinum NPs and
used tumour endothelial cells as a constant parameter. Using a 50 kVp x-ray source,
results showed that maximum dose enhancement, due mainly to Auger electrons,
occurred when the NP is closest to the nucleus and is able to deliver damage directly
to the DNA of the cells [63]. Therefore, depending on the biocompatibility of lanthanum manganite nanoparticles as a result of this study, it may be advantageous
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Figure 2.4: A representation of tumour internalisation of NPs via the EPR
effect. Taken from [39].

to pursue this approach to internalisation.
Although easy passage into the cell is achievable through ligand-receptor interactions, delivery to the site is often quite challenging and extremely delicate. It
has created design implications and introduced criteria for nanoparticles that must
be assessed for desirable results. Immediately after nanoparticles are distributed
intravenously, it encounters blood, which is a high ionic strength, heterogeneous
suspended solution [63]. This can cause agglomeration and sequestration of the
nanoparticles [64]. Decuzzi et. al. 2006, formulated a model that describes the
optimal volume for adhesive strength of ligands to cell receptors and found that
oblate nanoparticles are a more beneficial design parameter for cell interactions [65].
Therefore, efficacy of treatments is extremely dependent upon the chosen cell type,
pathways to these cancerous cells and the nanoparticle in question.

2.3.2

Cellular response to internalised NPs

The cellular response to nanoparticles is also very important in the sense that it
can be a source of toxicity and can limit the concentration levels that are used in
targeted therapy. A decrease in the size of nanoparticles, being one dimension lower
than 100 nm, results in a surface area increase due to its constituents becoming more
prominent on the outer surface [66]. Consequently, the increase in surface area leads
to an increased number of reactive groups on its surface, and it is these groups that
may cause harm to the cells. Reactive Oxygen Species (ROS) are molecular oxygen
species that play a major role in cell signalling and homeostasis [67]. This molecular
oxygen, through the reduction of one electron that is catalysed by NADPH oxidase,
produces O2− , a primary ROS. Exogenous forms of ROS production can be due to a
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result of metal NPs or metal ion catalysed reactions, however, it will vary amongst
different NPs and cell type [67]. ROS production in cells is normal and generally nonharmful, however, the toxicity lies in the cells ineffective use of antioxidant defence
against its overproduction from outside sources such as NPs [66, 68, 69]. LAGMOs
are expected to be increasingly toxic to cells with a corresponding increase in silver
doping level, due to its ability to create ROS. However, a characterisation process to
determine the best concentration with regards to ROS production should definitely
be investigated before conclusively stating its toxicity.

2.3.3

Nanoparticle Design

Specific NP size, shape and core composition are the main reasons for successful
accumulation within a tumour. Chithrani et. al. 2006, pioneered one of the first
studies in establishing a size dependency of NPs for cellular uptake (see Figure 2.5)
[71]. The results from this study showed that at 50 nm, gold NPs had the fastest
uptake in HeLa cells compared to 14 nm and 74 nm with 1.90, 2.1 and 2.4 hour
cellular uptake half-life, respectively [71]. The study also established that the mechanism responsible for the uptake into the cell was done though the invagination of
a ligand which binds to a receptor on a cells surface. The shape of the nanoparticle
was examined, with comparisons conducted between rod-like and sphere-like NPs
and established that spherical shaped NPs had higher probability of being taken in
by the cell [71]. These NPs, however, were made to be more accessible to the cell by
allowing citric acid ligands to be present on the outside of each nanoparticle. Nevertheless, accessibility has shown improvement when adjusting the surface chemistry
and may be utilised if Lanthanum Manganite isn’t internalised properly. Gratton et.
al. 2008, investigated specific shapes of nanoparticles for HeLa cells and found that
rod-shaped NPs had the highest internalisation [70]. This quality may be heavily
considered when trying to improve the nanoparticles internalisation, as it is unclear
on how it will interact specifically for 9LGS.

2.4

Cellular Response to Radiation

2.4.1

General Cell Response to Radiation

2.4.1.1

Cell Cycle and its effect on Radiation

Investigation of radiation dose enhancement is not fully dependant on an understanding of the governing physical phenomenon, but rather partially on the characteristics of the actual cell [27, 72]. The cancer cell cycle is a densely coordinated
system that aims to replicate DNA in the S (synthesis) phase, producing identi-
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Figure 2.5: A graphical representation of the gold nanoparticle accumulations
at different nanoparticle sizes. Taken from Chithrani et. al. [71].

cal chromosomal pairs, which later distribute into two equal daughter cells in the
M (mitosis) phase [73]. Entrance into each respective phase is managed by checkpoints named G1, which will refuse to replicate damaged DNA, and G2, preventing
segregation of abnormal chromosomes (see Figure 2.6) [74].

Figure 2.6: A visualisation of the cell cycle and what is occurring. The G0
phase is not shown. Taken from Hartwell et. al. [75]

A novel study conducted by W. K Sinclair and R. A. Morton characterised each
point of the cell phase with respect to its sensitivity to radiation and confirmed a
large degree of dependence [76]. Furthermore, survival rates were measured to be
much higher after irradiation for late S cells as opposed to cells shortly after their
transition into the synthesis phase. Figure 2.7 displays this relationship, emphasising on the idea that radiation treatment of cells in the G2/M phase will generate
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the greatest cell death. Therefore, nanoparticles must be directly investigated to
determine whether through their internalisation, there is any cell cycle arrest in any
of the cell phases.

Figure 2.7: Single cell surviving fraction curves for the different phases of the
cell cycle, including late S phase and early S phase. Taken from Sinclair et. al.
[76]

2.4.1.2

ROS: An indirect result of Radiation Damage

It is well documented that radiation damage to cancer cells will result in the induction of oxidative stress through an increase in the production of free radicals [77,
78, 79]. The hydroxyl groups of free radicals that are produced by the radiation are
the most important to note, as they cause the most damage to the cell. They do so
by being fired off near neighbouring molecules at an incredibly fast rate [78]. Their
production is often a direct result of the oxidisation of water, however, can also
be produced through interaction with secondary partially reactive oxygen species.
Often, the result of the hydroxyl damage will lead to the radiolysis of the cell, which
is the internal swelling and subsequent membrane rupture.
Although hydroxyl groups are the most produced ROS as a result of radiation,
there is still production of many other forms of reactive oxygen species such as
superoxides (O2 − ) and perioxinitrate ions (OONO− ). Radiation is known to cause
the overproduction of nitric oxides (NO), and in turn, this reacts with O2 − oxygen
species to produce OONO− . This is an example of secondary ROS production inside
the cell and is extremely harmful to the cell due to its high reactivity to molecules
in its environment [77].
Further characterisation of the ROS damage to cells as a result of radiation
shows the capabilities of damage to the cell mitochondria [80]. The damage to mitochondria is very prevalent in cells exposed to radiation especially at low doses and
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is often referred to as the target organelle [81]. Mitochondria occupy large proportions of a cell (up to 25%) and also attain the most abundance of ROS. Therefore,
upon interaction with radiation, damage will directly impose on its function with
free radical groups firing off within its vicinity. Mitochondria are responsible for cell
respiration and are the cells’ main source of energy [82].

2.4.2

9L Gliosarcoma Response to Radiation

9L gliosarcoma (9LGS) is a Grade IV biphasic neoplasm, containing both glial and
mesenchymal components [83]. It is being investigated in this thesis due to its exceedingly radioresistant nature, extremely short survival prognosis of approximately
4-12 months [84, 85] and as a great model for human gliomas [86]. In addition
to this, 9LGS genetic composition and functions are still being investigated today.
A comparative study by Reis et. al. 2000, characterised the genetic profile of
gliosarcoma and most importantly its similarity to the more standard brain cancer
Glioblastoma Multiforme (GBM) [87]. The major difference between GBM and its
variant, gliosarcoma, is the lack of overexpression of the epidermal growth factor
receptor (EGFR) for the latter.
Furthermore, all GBM cells acquire p53 mutations [88], while p53 mutations of
gliosarcoma were seen in approximately 26% of cases in a clinical evaluation of 19
cases [87]. p53 is a protein whose role is to act mainly as a strong mediator of the
G1-S and G2-M phase transitions [68, 73]. Still being studied today, the tumour
suppressor gene is also a coordinator for apoptosis and its purpose theoretically
suggests that a greater expression will create more apoptotic events from radiation
treatment [89, 90]. However, a study on the inhibition of functional p53 in A459
adenocarcinoma cells, showed an increase in sensitivity to treatment involving radiation and protein inhibition [90]. These results question the efficacy of treatment
outcomes when they are based upon the genetic profile of the tumour cell line being
investigated.
A study conducted by Datta et. al. 2002, investigated the relationship between
p53 proteins and oxidative stress, pertaining the hydroxyl group H2 O2 [91]. It
was found that the pathway to apoptosis was necessary through these proteins and
mutations of the p53 gene in the U373 glioma cell line caused resistivity to damage.
Therefore, as 9LGS has relatively low levels of p53 mutations in comparison to
glioma cell lines, such as U373 and GBM, it is possible that if there is toxicity due
to ROS it is mediated by this protein.
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Summary and Implications

The literature has pointed out the main mechanisms that will be involved in the
experimental aspect of this thesis and has made clear the processes occurring when
cells and nanoparticles will interact with radiation. The work of Hainfeld et. al.
2006, has been fundamental to the inception of the idea that high-Z nanoparticles
can be used to enhance dose [18]. However, the limitations of gadolinium nanoparticles, such as its relative toxicity to normal tissues, necessitates the investigation of
new nanoparticles, in particular with magnetic properties, in order to innovate and
improve both theranostic and therapeutic cancer industries. Lanthanum Manganite
nanoparticles doped with silver have been noted to have good biocompatibility in
one study, however, the concentration dependency of reactive oxygen species and cell
cycle interactions have not been defined. Furthermore, the overwhelming amount
of varying results regarding the combination of radiation and novel nanoparticles
warrants an extensive analysis on mechanism by which toxicity, if any, is caused.

Chapter 3
Methodology
3.1

Experimental Considerations

The validity and reliability of results is often best expressed through repetition and
technique. The care associated with using nanoparticles and cell lines are a testament to how important this statement is to this thesis. Mastering the skill of
maintaining a cell line is a major hurdle to overcome and often drives the research
result, especially when dealing with an aggressive brain tumour cell, 9L Gliosarcoma (9LGS), both vicious and delicate in nature. The bulk of the cell work in this
thesis heavily involves a calculated prediction of confluence inside a flask and targeting viability, surviving capabilities, or the cause of death. The two cell lines being
investigated in this thesis are 9LGS and Madin-Darby Canine Kidney (MDCK) epithelial cells for a very specific purpose. Using 9LGS, a Grade IV biphasic brain
tumour cell line, and MDCK, a normal tissue cell line, is an excellent way of investigating how potent a treatment is to cancer in comparison to its ability to leave
normal tissue cells unaffected. The nanoparticle LaMnO3 and La(1−x) Agx MnO3 will
be investigated throughout this thesis to trial its capabilities in vitro.

3.1.1

Culturing 9LGS and MDCK adherent cells

Two cell lines, 9LGS and MDCK, are used throughout the entirety of the experimental aspect of this thesis. Maintenance is controlled through the careful process of
passaging the aforementioned adherent cell lines in a T-75 cm2 flask once confluence
is achieved with 10 million and 6 million individual cells, respectively. Dulbeccos
Phosphate Buffered Saline (DPBS) (Ca− & Mg− ) is used to wash the cells of excess
media and the cells are lifted using 2 mL of Trypsin (EDTA) when passaging. All
other culture materials, including flasks, dishes and plates were adjusted for confluence based on growth area (cm2 ) and this can be seen in Appendix A. Cells are
then counted using the haemocytometer (see Figure 3.1) and seeded based on the
22
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growth culture they are growing in, according to:

cells
×104 ×DilutionF actor×V olume in f lask(mL)
quadrants
(3.1)
days×24hours
Doubling
time
Seeding N umber = CT × 2
(3.2)

N umber of cells in f lask(CT ) =

Figure 3.1: Schematic diagram of one half of a haemocytometer used for counting cells.

All cells that are to remain viable must be maintained in a controlled humidified
environment inside an incubator, which keeps the temperature at 37◦ C and carbon
dioxide levels at 5%. The two cell lines vary in doubling time where MDCK has
a 16-hour doubling time and 9LGS, 36 hours. Another major difference between
the cell lines includes MDCK exhibiting significantly higher sensitivity to radiation
compared to 9LGS.

3.1.2

Nanoparticle Synthesis

The spray pyrolsis method was used to synthesise silver-doped lanthanum manganite
nanoparticles. This is done by mixing lanthanum oxide (La2 O3 , 99.9% purity),
manganese nitrate (Mn(NO3 ): 97.0% purity) and silver nitrate (Ag(NO3 )2 :(x)H2 O
99.0% purity) precursors in a solution and spraying at a vertical tube furnace at 900
◦
C. The resultant silver-doped lanthanum manganite nanoparticles are retrieved
using an extraction pump. Finally, several days after extraction, the NP structure
is relaxed by annealing at 800 ◦ C for four hours.
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Preparing Lanthanum Manganite Nanoparticles for
in-vitro Use.

Prior to adding LAGMO nanoparticles to cell cultures, they must be dispersed in
a liquid and the number of aggregated NPs must be minimised. This is achieved
through adding PBS (Ca− & Mg− ), in most experiments, or Dulbecco’s Modified
Eagle Media (DMEM) to the nanoparticles in a glass vial containing the weighed-out
NPs and placing them inside a sonication bath. The sonic vibrations sent through
the water within the bath ultimately cause the dispersed LAGMO NPs to shake off
each other and form individual NPs along with smaller, minimised agglomerates.

3.2

Experiments

The experiments conducted for this thesis aim at targeting certain aspects of the
cell limitations and integrity with regards to its treatment. Cells were examined for
the extent of damage to its DNA, membrane and/or environment.

3.2.1

Cell Viability and Integrity

There are many different approaches to understanding the strength of a cells’ integrity and how viable they are after being treated with LAGMO NPs. One strategy
exhibited to explore the viability of 9LGS and MDCK quantitatively, was by exposing the cell lines to MTT tetrazolium salt.

Figure 3.2: A 96 well plate containing MTT formazan solubilised with DMSO.
It is sitting in the SpectroMax plate holder ready to be analysed.

The cells were seeded in a 96-well Greiner plate for 3-4 days in 100 µL of complete DMEM media and then replaced with media that contains suspended NPs at
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concentrations of (0, 5, 10, 20, 50, 65, 85, 100, 250, 500 and 1000) µg/mL. After
24 hrs of exposure to the NPs, the media is then replaced with 110 µL of media that is 10% MTT and left inside an incubator for 4 hours. In the presence of
cells, the aforementioned salt is enzymatically reduced to a purple formazan which
can then be solubilised by adding 200 µL of DMSO. The colour of the solution is
directly proportional to the number of viable cells present and therefore, can be
analysed using the SpectroMax 384 Plus spectrophotometer microplate reader at
545 nm wavelength. The results were normalised to a negative control, where cells
are not treated with NPs. Two positive controls are also included, the NPs in DMSO
without MTT and blank wells with only DMSO and this is to deduct the effect of
opacity from sedimented NPs and the material of the plate. The error that will
be presented for MTT results will involve a standard deviation of the population,
which involves triplicated wells read with the Spectromax at least three times. This
experiment generally takes a week to conduct, and was repeated for 0%, 2.5%, 5%
and 10% silver-doped Lanthanum Manganite nanoparticles on the 9LGS and MDCK
cell lines.
The qualitative and partially quantitative approach to witness the cells ability
to continue its natural mitotic process after NP treatment is through imaging. The
Essen Bioscience IncuCyte ZOOM is a machine that combines fluorescence and
phenotypic cellular analysis. The experiments conducted in this thesis pertaining
the IncuCyte all involve a 24-well Greiner plate and within it, cells seeded for the
desired time it will be imaged. The imaging technique used by the IncuCyte ZOOM
involves, a 10x lens objective that auto-focuses on cell populations for images and
has green and red wavelength fluorescence. Cells are also protected as the whole
IncuCyte is stationed inside an incubator, which is maintained at 37◦ C and 5% CO2 .
This allows them to be left undisturbed throughout the experimental period, while
receiving real time data on confluence and cell damage per well.
The 24-well plate was optimal for all of the experiments conducted on the IncuCyte as it allows room for negative controls along with high precision confluence calculations of all four doped LAGMO NPs. Experiments involving 9LGS and
MDCK work best over 3-5 days, however, extending this time period proves to have
great benefit in understanding the growth and behaviour of the cell line. For experiments containing 9LGS, cells were seeded for 200 000 at confluence, whereas cells
containing MDCK were seeded for 160 000 at confluence to account for their size.
Co-culturing 9LGS and MDCK was also investigated by adding both cell lines
into a well with each cell line being seeded for 120 000 and 80 000 cells respectively,
to achieve a confluence number of 200 000 cells. Treatment, involving NPs at 50
µg/mL, was typically added 24 hours after the wells were seeded and remained in
the IncuCyte for the duration of the experiment. Alongside the treatment, 2 µL of
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Figure 3.3: IncuCyte machine setup inside an incubator.

1 mg/mL Propidium Iodide (PI) was added to the well. PI stains DNA and RNA
found outside the cell as it is unable to penetrate an intact cell membrane of live cells
and, therefore, is excellent for categorizing damage such as membrane rupture/lysis
and leakage. Additionally, in the case that a cells’ membrane or nucleus is ruptured
and non-viable, the PI dye can then enter and stain inside the cell. Along with
brightfield images, the IncuCyte flashes 535 nm wavelength light at 0.4 s exposure
and detects emissions at 617 nm wavelengths when programmed to do so. This form
of imaging allows the IncuCyte ZOOM software to calculate confluence, PI per well
(PI/well) and many other parameters. The software also calculates and outputs its
own standard error for confluence and PI per well, which is presented in this thesis
with the results. Taking into account the restriction of only 24-wells in a plate and
facility booking difficulty, the experiments took over several months to complete.
Fluorescence Imaging, a technique employed to understand the extent of damage
to the cells by exposing them to fluorescent dyes. Three dyes were used, Propidium
Iodide (PI) (Excitation/Emission (Ex/Em): 535 nm/617 nm), Hoechst (Ex/Em:
361 nm/497 nm) and dihydrodichlorofluorescein diacetate (DCF) (Ex/Em: 492 nm/
527 nm). The function of the Hoechst dye is to penetrate the cell nucleus and stain
the DNA and RNA of live cells, which will provide information mostly on nucleus
shape and any damage it has experienced. The most important stain concerning this
thesis, however, is DCF as it targets the reactive oxygen species in the cell cytoplasm
and provides a relatively proportional intensity based on the level of ROS present.
For T-25 cm2 flasks, 10 µL of 1 mg/mL PI and Hoechst were added and incubated
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for 20 minutes. After 20 minutes had elapsed DCF was added to the flask and left
to incubate for 40 minutes. The volume of DCF added to the flask was calculated
using the following equation:
C1 V1 = C2 V2

(3.3)

where C1 , C2 are initial and final concentrations and V1 and V2 are initial and
final volumes. DCF concentrations for 9LGS and MDCK are 10 µM and 15 µM, respectively. MDCK requires a higher concentration of DCF due to the fact that they
are generally larger and as a result have considerably greater amounts of reactive
oxygen species. The emissions of each dye are captured using the spectrums TexasRed for PI, DAPI for Hoechst and the FITC for DCF. Another form of imaging,
known as phase imaging, was also conducted alongside Hoechst staining in order to
visualise internalisation and other cell interactions. Phase imaging is a technique
that utilises the phase shifts as a result of light passing through a transparent object. It allows cell-like objects to show structure by displaying the cell membrane
dominantly with defined edges.

Figure 3.4: Fluorescent Microscope used for imaging of fluorescent dyes.

Preparation for the experiment involves usage of T-25 cm2 flasks, where cells are
seeded for 2.5 million at confluence and given the following treatment 24hrs prior.
Treatment to the cells involved, 0%, 2.5%, 5% and 10% LAGMO NPs at 50 µg/mL.
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Flow Cytometry for Cell Cycle Analysis and ROS
Quantification

Flow Cytometry is an important technique that provides data on the internalisation
of NPs, ROS production and cell cycle. The technology holds strong research value
as it is able to provide information on cell condition and cell trends immediately
off running a single sample. It does so through the analysis of scattered light as a
laser beam strikes each cell travelling in a stream of fluid, emitting fluorescence (see
Figure 3.5).

Figure 3.5: Schematic diagram of the flow cytometer and its principle funtion.

Light scattered off the cells is affected by the internalised nanoparticles, the
granularity and also the cell constituents. Light Scatter can be split into two categories, forward scatter (FSC) and side scatter (SSC), and can be used to identify
a cell line based on its trend. FSC is the result of slightly diffracted light that is
marginally off-axis from the incident beam which relates to the size of the cell and
the surface area. SSC is the result of reflected and refracted light from interacting
with the internal components of a cell that reaches a detector approximately 90
degrees from the incident beam.
Cells are prepared in a T25 cm2 flask for confluence and treated with LAGMO
NPs 24 hours prior to experimental analysis. The cells are then lifted from the
flask using Trypsin, counted to retain 1 million cells and placed inside a 15 mL
falcon tube with media in order to stop the Trypsin process. Centrifugation of cells
involves placing the 15 mL Falcon tube in a centrifuge for 5 minutes at 1500 rpm
for 9LGS and 1200 rpm for MDCK. After the cells are centrifuged, the supernatant
is removed, leaving the cells behind. The cells are then resuspended with 500 µL
of PBS by pipetting up and down, allowing them to be ’washed’ as they are spun
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(b) BD-LSRII

Figure 3.6: The (a) BD-Fortessa and (b) BD-LSRII flow cytometers used for
experimental analysis.

again in the centrifuge. At this stage the cells are ready to be processed for ROS
analysis or cell cycle analysis based on the dye used.
The data is processed through a fluorescence-activated cell sorter (FACS) FACSDiva software that provides data on mean SSC value, which is proportional to internalisation. It also analyses the emitted fluorescence based on its intensity and
how many cells correspond to that intensity. A minimum of at least 20 000 cells
were passed through the flow cytometer to produce results in both DCF and PI flow
cytometry. Flow cytometry cell experiments involved all doped nanoparticles. The
data on each nanoparticle presented in this study is limited to the time (usually one
week) it takes to setup and perform flow cytometry experiments.
3.2.2.1

ROS Flow Cytometry: Reactive Oxygen Species Quantification

ROS flow cytometry involves adding 10 µM of DCF to resuspended cells that have
been washed with PBS once, and left to incubate for 30 minutes. After incubation,
the cells are then washed two times to ensure any excess DCF that is in the PBS
does not run through the BD LSRII or Fortessa machine. This also allows for the
cells to be then sent through to the flow cytometer suspended in pure PBS and
emit fluorescence mainly from the ROS present inside the cell. Lastly, the cells are
transported in darkness to the BD-LSRII. The flow cytometer uses powerful lasers,
and in this case a blue (488 nm) laser with a beam height of 15 ± 3 µm and beam
width of 75 ± 15 µm. The DCF will act to stain all ROS radicals and activate
upon excitation from the laser. Finally, the data is sent through the FACSDiva
software, which allows for comparison of treatments to a control by producing a
mean fluorescence value. Changes in ROS levels in cells can also be seen using an
intensity versus counts graph where shifts in the curve correspond to higher mean
levels of ROS and widening of peaks provides ROS data on whole cell populations.
From the ROS mean values, total ROS of a population can be calculated and will be
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used to describe fluctuations in its value. All (0-10)%-LAGMO NPs are incubated
with both cell lines at 50 µg/mL 24 hours prior to experimentation. 0%-LAGMO
NPs are also explored at concentrations 0, 25, 50, 85, 100, 250 µg/mL. The data
presented for DCF flow cytometry for all NPs, will consist of a normalisation to
the internalisation and ROS values in the control (no NPs) cells. Furthermore, all
errors in the data will be presented as the standard deviation of the population,
which consists of at least three sets of 20 000 cells receiving the same treatment.
3.2.2.2

PI Flow Cytometry: Cell Cycle Analysis

PI flow cytometry is the technique used to show the cell cycle in order to understand
the direct effect that a specific treatment has on a cell line. This experiment requires
exclusive DNA staining, and therefore necessitates the removal of RNA, which is
known to bind to PI. This is achieved through the introduction of Ribonuclease
(RNase), in a later step of the experiment, as it catalyses the degradation of RNA.
Furthermore, PI alone is unable to penetrate the cell membrane of live cells and
therefore will require a fixing step. The fixing is achieved by adding 1 mL of icecold 100% methanol to a palette of cells in a dropwise manner to avoid aggregation.
They are then resuspended with the methanol and placed in an ice-bath for 30 mins
to allow for fixing, while gently being shaken throughout this time. The cells are
then washed with 2 mL of PBS three times to ensure no traces of methanol are left
behind, eliminating the risk of damaging the BD Fortessa flow cytometer. At this
stage, the PBS is then replaced with 200 µL of PI master stock, containing 20 µL of
RNase (100 µg/mL) and 8 µL of PI (40 µg/mL) dispersed in PBS and left inside an
incubator for 1 hour. The cells are then resuspended and transferred to microtubes
in darkness for analysis on the flow cytometer. PI has an excitation maximum of
535 nm and an emission maximum of 617 nm, therefore, the 488 nm blue laser
successfully targets this. Cells are then gated by plotting side-scatter area (SSCA) against forward-scatter area (FSC-A), where mainly singlet cells are selected
and gated to remove debris. Three further gates are used on the PI-fluorescence
histogram, allowing an indication of the percentage of cells in each gate. This
will correspond to the percentage present within a cell cycle phase. The PI-Flow
Cytometry technique was performed on all (0-10)%-LAGMO NPs incubated with
9LGS 24 hours prior to experimentation.
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This thesis involves a analysis of the damage that treatment has on cells, however,
the culmination of these results regarding cell response to treatment all aid the main
experiment at hand, cell irradiation. A cell survival curve is the most desired result
and it involves a 0, 1, 2, 3, 5 and 8 Gy dosage to the cells using 125 kVp orthovoltage
x-rays.
All irradiation of cells was performed at the Prince of Wales Hospital, Randwick, NSW, Australia. The source of radiation was the Nucletron Oldelft Therapax
DXT 300 Series 3 Orthovoltage x-ray machine (Nucletron B.V., Veenendall, The
Netherlands). In preparation for an irradiation experiment, cells must be seeded for
confluence in a T-12.5 cm2 flask at densities, 1.3 million and 750 000 for 9LGS and
MDCK, respectively. To optimise the cells for radiation and ensure the cells are
in a state of quiescence, the cells are irradiated at approximately 90% confluence.
The cells were irradiated as a monolayer on a flask 6 mm in depth with complete
DMEM media surrounded by solid water for full scatter conditions. The 125 kVp
x-ray source had a beam current of 20 mA and a dose rate of 2 Gy/min at a source
to flask distance of 30 cm. It uses inherent filtration of 3 mm of beryllium, an additional filtration of 0.1 mm copper and 2.5 mm aluminium resulting in a beam half
value layer of 6.58 mm of aluminium. Cells are monitored closely and passaged up
to at least 12 times with 4-5 days between each passage in order to ensure they are
at their healthiest (highest plating efficiency) when irradiated.

Figure 3.7: A petri dish of 9LGS cell colonies stained with crystal violet and a
red line across each, marking it as one counted colony.

The treatment will involve cells, which are irradiated without pre-treatment of
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LAGMO NPs (control) and also with pre-treatment of 0% silver-doped LAGMO
NPs. After irradiation, they are detached with Trypsin and counted. Proceeding
the counting of the cells, they are seeded at low density into a 10 mm diameter
petri dish containing 10mL of complete DMEM media. The seeding numbers are
determined to optimise the following set of equations:
P lating Ef f iciency, P E =

N umber of Colonies
Seeding N umber

Surviving F raction, SF (%) =

P ET reatment
× 100%
P EControl

(3.4)

(3.5)

Each seeding number is triplicated and all treatments above 0 Gy are given
three different seeding numbers in order to ensure colonies in at least one triplicated
seeding number will grow. Control flasks without radiation are also processed at
different timepoints during the lengthy experimental process. The cells were then
incubated at 37◦ C and 5% CO2 for 15 doubling times, where they are left to grow into
colonies. At the conclusion of the three weeks the plates were washed with DPBS
(Ca+ /Mg+ ), then fixed and stained at the same time with a solution comprised of
75% Ethanol (v/v) and 25% Crystal Violet (v/v).
The final step involves counting the colonies on the plates, which have grown
over the course of the 15 doubling times inside the incubator. A colony is defined
as a group of cells that has grown explicitly from a single cell. For this experiment,
the number of surviving colonies will be defined as a group of cells with more than
50 individual cells. In the case that there are less than 25 colonies, the plate will
be considered statistically insignificant. Additionally, colony counts above 300 will
also be left out due to increased potential of cross-over between adjacent colonies,
thus making it very difficult to distinguish between singular or aggregated colonies.
The SF values that are presented are normalised to the control (No NPs) and the
corresponding error in the SF value will be presented as the standard deviation across
a population, which involves all plates of statistical significance that contribute to
its result. Since the SF of cells follows the linear quadratic model, the data is curve
fitted according to its dependance on dose:
SF = e−(αD+βD

2)

(3.6)

The totality of the experiment will take 3 months to complete and consequently,
there was large difficulty in repeating the experiment during the time that was given
to conduct this study.
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Cytotoxicity Assay

A cytotoxicity assay differs very slightly to the clonogenic assay as it does not deal
with radiation and the cells are grown and treated in a T-25 cm2 flask as opposed
to the T-12.5 cm2 flask. Its’ purpose is to directly analyse the direct impact of a
treatment to cells. It will describe the growth capability of the cell and provide
insight as to how much damage will be caused once performed with radiation. 0%LAGMO NPs at concentrations 10, 20 and 50 µg/mL were incubated with 9LGS 24
hours prior to the plating of cells. The corresponding error presented in the results is
calculated in the same manner as the clonogenic assay. This experiment time-wise,
similar to the radiation experiment, will require the cells to be passaged at least 12
times, and therefore, generally takes 3 months to fully complete.
3.2.3.3

Incucyte technique following radiation

Another unique technique performed using radiation, involved irradiating samples
and placing them in the IncuCyte for long periods of time. This will imitate a
clonogenic assay as the cells, over a week, will be encouraged to grow in the same
way as the petri dish, but in a much smaller surface area. It will also provide images
with PI staining, displaying the radiations’ effect on 9LGS and MDCK cells. The
cells are prepared in a T-12.5 cm2 flask, irradiated at two extremities, low dose (2
Gy) and high dose (8 Gy), and seeded for 7 days in a 24-well plate. Each row of
the plate will be seeded at different densities in case the cells experience difficulty
growing after the treatment. The plate design can be seen in Figure 3.8. For 9LGS
the seeding numbers were calculated for a total of 200 000, 300 000, 400 000 and
600 000 cells at confluence, while MDCK was seeded according to a total of 160
000, 240 000, 320 000, 480 000 cells at confluence. Flasks that are not treated
with nanoparticles prior to radiation will be seeded in one plate, while cells pretreated with 20 µg/mL of 0%-LAGMO nanoparticles will be seeded into another.
Both plates will require two wells for each dose to allow an average calculation of
confluence and PI per well and standard error in each. Curve fitting, via the ’least
squares’ technique, was used for 9LGS cells in order to extrapolate the exponential
increase in confluence, corresponding directly to the doubling time of the cells. The
standard error was extrapolated from the curve fitting function.
Growth hinderance, a term coined for the purpose of this thesis, will highlight
the NP-effect alongside radiation on cells similar to a dose enhancement value but
instead represents a confluence reduction. The growth hinderance ratio (GHR), is
the ratio between the confluence of control cells (no NPs) and the nanoparticle pretreated cells at the same dose. It is calculated according to the following equation:
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Conf luenceControl
Conf luenceT reatment

(3.7)

The error in its value was calculated using the fractional uncertainties in the
confluence of the control cells and NP-treated cells.

Figure 3.8: A 24-Well plate showing the experimental design for incucyte following radiation. The confluence numbers in blue were used for 9LGS-containing
plates and the confluence numbers in green were used for MDCK-containing
plates.

The experiment is performed on both 9LGS and MDCK cell lines in order to
directly address selectivity. The cells will be processed using the IncuCyte ZOOM
software for details on confluence and PI per well, which also includes an extrapolated standard error. This experiment is conducted separate to the clonogenic assay
and also requires the cells to be optimised at a high PE ensuring that they will grow
as expected inside the 24-well plate.
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Chapter 4
Results
4.1

Effects of Un-doped Lanthanum Manganite
(0%-LAGMO) to 9LGS Gliosarcoma

4.1.1

Refining the preparation of Lanthanum Manganite

Before addition of NPs to 9LGS can be performed, it is essential to refine the pretreatment of the NPs themselves. The sonicator is a crucial instrument that must
be used almost directly before the NPs may enter the environment of the cell. This
is because of their tendency to become attracted to each other through slightly
magnetic interactions and sedimentation.

(a) 20 minutes

(b) 45 minutes

Figure 4.1: Sonication of undoped Lanthanum Manganite for (a) 20 minutes
and (b) 45 minutes. Image taken after 3 days incubation.

It’s clear in Figure 4.1 that increasing the sonication time improved both the
distribution of nanoparticles present throughout the image and also the number of
36
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Figure 4.2: 9LGS absorbance values taken from the SpectroMax after the
cells were incubated with undoped Lanthanum Manganite (0%-LAGMO) for
one day and three days.

cells present. The method of sonication was improved slightly throughout the study
and was found to be most effective by sonicating for one hour and vortexing the
nanoparticles halfway through.

4.1.2

Preliminary Toxicity Tests on 9LGS

The MTT assay is an important technique in providing an early understanding of
the LAGMO NPs effect on 9LGS as there is no previous research on how they will
interact with each other. It specifically indicates the cells ability to continue its
growth after receiving its treatment, which in this case was given 24 hours and 72
hours before MTT is introduced to the cells. It was the first experiment conducted
in this thesis in order to discover the concentration of NPs that will be suitable for
further experiments. The results can be seen in Figure 4.2.
As a preliminary experiment on the LAGMO NPs, the results presented in Figure 4.2 are quite promising. There is a strong indication that at 24 hours incubation
with the 9LGS, the cells are mostly unaffected by the NPs. We can extrapolate from
the graph that cells are 100% viable at a relatively high concentration of 85 µg/mL.
However, the three-day MTT shows that at this concentration, the cells are 26.9
± 0.6% viable. This indicates that cell growth and population after more than 24
hours of exposure to the NP is extremely affected by their presence. For this reason,
a more suitable concentration to probe for further experiments would be one that
does not destroy the majority of the cells’ ability to continue its mitotic process.
The point at which there is 50% viability is referred to as IC50 and it is at
this point on the three-day MTT that a suitable concentration for further analysis
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(b) NPs-LaMnO3

Figure 4.3: PI (red), Hoechst (blue) and DCF (green) stains for 9LGS with
(a) no treatment and (b) 24 hours incubation with 0%-LAGMO at 50 µg/mL.
The DCF stain presents details on cell condition and morphology along with
a visual representation of ROS levels within each cell

can be extrapolated. This occurs at 48 µg/mL (≈ 50 µg/mL), which interestingly,
has a viability of (100 ± 15)% at 24 hours exposure to the NPs. The large errors
associated with the one-day MTT directly correlated to the slight variations in the
number of cells present in the well and also the steps where NPs, MTT and DMSO
are added to the plate.

4.1.3

Visualisation of the interaction between 0%-LAGMO
NPs and 9LGS

At the concentration of 50 µg/mL, the NPs may have an effect on the cells that isn’t
measurable via MTT at 24 hours after addition into the flask. For this reason, a
fluorescence imaging experiment was setup to understand the condition of the cells
and whether the NPs are affecting its membrane integrity.
The images that are taken with the fluorescent microscope, show evidence of
dying cells, which can be directly correlated to their DCF (Green) emission intensity,
as they often appear to have irregular DCF distribution in comparison to the cell
membrane and are brighter than the surrounding unaffected cells. This is evident
in the control flask as the 9LGS cell line induces its natural apoptotic process to
optimise its environment for further mitosis. However, this is not the case in Figure
4.3 (b) where it is clear that the general population of cells display a significant
increase in DCF as a result of the NPs. Although it is clear that there is slightly
more background DCF in (b) than in (a), it can still be stated that (b) has greater
amounts of DCF present within the average cell. We can make this conclusion as the
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cells are receiving the same molar concentration (10 uM) of DCF and same exposure
time as the control. Imaging with DCF is extremely difficult as it experiences
photobleaching within seconds of its exposure to 495 nm wavelength excitation, and
for this reason it is hard to reproduce exact background conditions over different
flasks.
Furthermore, there is a significant increase in the number of PI spots in Figure
4.3 (b) compared to (a), indicating that the cells are experiencing damage over a
greater area. Cell damage, represented by PI stains, is mostly present in the outline
of the cell membrane in (b), which can be noted as a small red emission on the edge
of the cell, known as a membrane leakage. The results from this experiment indicate
that at the NP concentration of 50 µg/mL, the cells are in fact damaged but are still
at this stage considered viable as the nucleus appears mostly intact. This supports
the previous MTT result, which presented 100% viability at this concentration of
NPs. A rupturing of the cell nucleus will cause the PI signal to appear purple as it
is combined with the staining of Hoechst and this is also present in image (b).

Figure 4.4: A closer look on the fluorescent microscope showing (a) internalisation and (b) apoptosis, using a phase imaging technique along with
Hoechst (Blue) staining.
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A closer look at the cells to further understand the 0%-LAGMO NPs interaction
with 9LGS using phase imaging presents fascinating results. In Figure 4.4 (b), it
is clear that the NPs are being taken up by the cancer cell through endocytosis,
though this may not be the only way. In addition to this, both cells presented
in the image have taken up more than one NP. This is extremely important as it
indicates that the presumed ROS-inducing effect of the LAGMO NPs on the cell
have the potential to be amplified simply by the cells unique tendency to take up
materials in its environment. In addition to this, the NPs seem to be situated within
approximately 1 µm of the cell nucleus, which could be advantageous when combined
with radiation. It should also be taken into consideration that the multiple NPs seen
inside the cell are also aggregates of many smaller NPs. Figure 4.4 (b) displays a
remarkable representation of a cell undergoing apoptosis due to the NPs’ ability to
cause 9LGS death. This type of death can be seen in a few cells in this image. From
both techniques of imaging, it is certain that nanoparticles do show signs of toxicity
but more importantly the possibility of having multiple radiation enhancement sites
within one cell and at a close proximity to the DNA critical targets.

4.1.4

Flow Cytometry: Investigating the mechanisms of cancer cell death.

(a) ROS Histogram

(b) Normalised ROS and internalisation

Figure 4.5: Flow Cytometric analysis of cells with no treatment compared
to increasing concentrations of 0%-LAGMO as (a) a Histogram plot of the
ROS and (b) all treatments normalised to the control cells’ ROS and internalisation.

The flow cytometry data is provided in an attempt to support the hypothesis
of unregulated ROS increase taking place inside cells as a main cause of 9LGS
cancer cell death. Figure 4.5 (a) displays a histogram of the number of cells plotted
against its corresponding fluorescence intensity as the cells are excited with a 488
nm wavelength blue laser. The response of 9LGS to 0%-LAGMO NPs becomes
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quite obvious, displaying an immediate extrapolation of population shifts and curve
broadening. These histogram features correlate to a different indication of ROS
dependant cell damaging effects. A shift in the peak, as shown in concentrations
(0-80 µg/mL) in graph (a), corresponds to a shift in the average ROS level inside
the cells. The peak shifts in fluorescence observably stop at concentrations above
80 µg/mL indicating a maximum amount of ROS that the cells are producing as a
response to the NPs.
The broadening of the histogram describes the variance of ROS levels within the
cell population itself, highlighting that cells are having different responses to NPs in
their presence. This may correlate directly to a number of different occurrences such
as, multiple nanoparticle intake of an individual cell or tightly packed cells prior to
the experiment. Histogram broadening becomes prominent in higher concentrations,
more specifically above 50 µg/mL. This is most likely due to cells taking up more
NPs, a direct effect of increased abundance, and thus experiencing an amplified ROS
increase. Additionally, doublets and triplets passing through the laser, debris and
cells in different phases of the cell cycle make a minor contribution to this effect.
Taking a more quantitative approach to the data received using the FACSdiva
software confirms the results seen in (a). In Figure 4.5(b), for concentrations of
up to 80 µg/mL, the mean internalisation of NPs increases significantly, however,
the resulting ROS signal is increasing at double the rate. Mean internalisation
reaches it maximum at 250 µg/mL, however, there is a sharp drop off in the ROS
intensity. This is likely due to the threshold of characteristic ROS levels that 9LGS
cancer cells can withstand before its antioxidant defence system fails to protect them.
Additionally, another factor that may have affected this sharp drop in value is the
inevitable NP agglomeration at higher concentrations, which will in turn reduce
surface area to the cells. This can affect growth and also the stability of the cells in
their environment.
To fully characterise the undoped nanoparticle, 0%-LAGMO, it is essential to
see how the cancer cell line can grow after treatment with nanoparticles. This was
achieved through attaining a surviving fraction of cells using the cytotoxic plating
method.
The impact of the undoped nanoparticle on the cancer cell line becomes evident
when analysing the result of colony growth over three weeks (see Figure 4.6). Relatively low concentrations of NPs such as 10 & 20 µg/mL, although showing no effect
to the viability at 24 hours, seemingly affects how the cells continue to grow when
they need to proliferate. It’s quite possible that the cells experience overwhelming
ROS levels, as evidenced in the flow cytometric data, which ultimately is at a level
high enough to impair growth. The result may also indicate that the cells are unable
to repair after they’ve been exposed to Lanthanum Manganite. This is even more
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Figure 4.6: Surviving Fraction of 9LGS after 24 hour incubation with increasing concentrations of 0%-LAGMO NPs

prominent at 50 µg/mL, where the surviving fraction is (37 ± 3)%. Although this
seems to be very toxic, it may in fact be very beneficial to a cancer cell line such as
9LGS since it is very resistant to radiation treatment.
Combining the results from the previous experiments, conclusively suggests that
the NPs provide the most balance between toxicity and survival at 50 µg/mL. The
evidence that backs this claim is prevalent where cells are exposed to a large number
of NPs with minimised cell damage up to and at 24 hours incubation time with 9LGS.

4.2

Increasing doping in silver-doped Lanthanum
Manganite and its effect on 9LGS

4.2.1

Comparing the toxicity of 0-10%-LAGMO Nanoparticles

The results regarding undoped Lanthanum Manganite is quite telling of the effect
that lanthanum may have on the radioresistant 9LGS cells. In addition to undoped
LAGMO NPs, three different levels of silver dopant replaced lanthanum ions in its
rhombohedral structure. These doping’s include 2.5%-La0.975 Ag0.025 MnO3 (2.5%LAGMO), 5%-La0.95 Ag0.05 MnO3 (5%-LAGMO) and 10%-La0.9 Ag0.1 MnO3 (10%-LAGMO).
The immediate question that must be answered is, will these doped NPs decrease
or increase the toxicity to cancer cells? The interest lies in the latter as an increase
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in toxicity could potentially deem the nanoparticles very potent alongside radiation
dose enhancement. Furthermore, an increase in toxicity may be beneficial outside of
radiation therapy and instead present potential to be used for chemotherapy. The
possibility of introducing silver ions to the environment of cells must be deliberated
due to its history of being toxic to cancer cells [84]. Another MTT assay was performed on all the doped nanoparticles being investigated to understand the effect of
adding silver ions to the structure of Lanthanum Manganite.

Figure 4.7: An MTT assay on 0-10% LAGMO NPs incubated with 9LGS
for 24hrs.

Immediately, the most notable difference amongst the doped NPs (see Figure
4.7), is the clear increase in toxicity as we introduce the silver dopant. The concentrations that has given a 100% viability for 9LGS with 0%-LAGMO NPs drops
significantly for 2.5%, 5% and 10%-LAGMO NPs, especially at higher concentrations. This suggests that the addition of silver certainly makes the nanoparticles
more damaging to 9LGS. Further, it suggests that an increase in the dopant level
of silver in the lattice structure of these NPs will cause a direct increase in its toxicity. The results also strongly suggest that the mechanisms governing the toxicity to
the cell line, due to an introduced silver dopant, are more rapid than the undoped
nanoparticles.
Clearly, all nanoparticles are affecting the cancer cells in a damaging way, and it
appears as though the dopants induce relatively similar levels of increased toxicity to
9LGS. The easiest way to analyse all four NPs and their interaction with the cancer
cell line is through IncuCyte analysis. Real-time images, confluence and PI mask
images that can be extracted directly from the IncuCyte ZOOM software helps
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in providing an understanding of cell behaviour and most importantly cell-to-NP
interactions.

(a) Control

(b) 0%-LAGMO

(c) 2.5%-LAGMO

(d) 5%-LAGMO

(e) 10%-LAGMO

Figure 4.8: Incucyte images showing the PI fluorescence emitted from the
cells as a result of different treatments (0-10% - LAGMO) incubated for 24
hours.

It’s quite evident in Figure 4.8, that all NPs being investigated not only caused
an increased average damage over a larger area in the plate compared to the control
but also a difference in damage amongst the NPs themselves. The difference in
toxicity of 0%-LAGMO from the silver-doped NPs becomes quite obvious in these
PI mask images and is further confirmation of the increase in toxicity that was
presented in the MTT assay. Furthermore, it is starting to become quite definitive as
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to what NP would pose the most suitability in conjunction with radiation. Radiation
damage will be most prominent at the molecular level and if these silver-doped NPs
are causing an even larger increase in ROS levels with respect to undoped NPs it will
increase the difficulty in determining a surviving fraction. In this case, investigating
the dose enhancement as a result of the presence of undoped lanthanum Manganite
may be the most appropriate approach.

4.2.2

Elucidating the relationship between silver-doped Lanthanum Manganite and cancer cell death.

The IncuCyte images substantiate the theorised increased toxicity to 9LGS by addition of silver ions to the NPs lattice structure. With the understanding that silver
ions may cause ROS generation within a cell, another flow cytometry experiment was
setup as confirmation. The results presented in Figure 4.9, act in a way to provide
evidence of an increase in toxicity as the doping of silver is increased. However, this
trend is not the case for 10%-LAGMO NPs as there is a sharp drop-off in relation
to the rest of the treatments. It should also be noted that all NPs exhibit a similar
SSC signals to the control and therefore, is quite telling of the corresponding ROS
values. 5%-LAGMO NPs amplifies the mean ROS value within each cell 11-fold,
thereby confirming it as the main mechanism behind the cell death witnessed with
the IncuCyte images. All other NPs actuate the same cell death mechanisms as it
is clear the normalised mean ROS values are enough to disturb the cell membrane
and eventually cause death.
However, this is not enough information to explain the sharp drop-off in ROS of
10%-LAGMO NPs in comparison to 2.5% and 5%. Cell viability analysis, IncuCyte
images and flow cytometry indicate that 10%-LAGMO NPs exhibit similar, if not
greater, toxicity to 9LGS through pathways triggered via increased total ROS over
a population. By visualising the cells’ response to each NP through internalisation
of at least one NP, it may become more apparent of the exact reasoning behind this
inconsistency of theory (see Figure 4.10).
Through careful analysis of the control (unaffected) 9LGS, its most noticeable
features point out the oval-shaped nucleus, fibroblast-like membrane and low average
DCF distribution throughout its cytoplasm. As we assess the condition, however,
of each cell and its condition after at least one internalised NP, the trend becomes
quite clear. All four NPs are causing a large increase of ROS and this is causing
direct damage to the nucleus with a clear cleavage of its structure. This is a direct
result of the pathways that are prompted by the ROS firing off within the cytoplasm
of the cell. Celardo et. al. 2011, confirmed that DCF levels within the cell increase
according to the type of damage to the nucleus, more specifically stating that there
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Figure 4.9: The total ROS and mean internalisation of 9LGS with each NP
at 50 µg/mL normalised to the control’s (No NPs) respective total ROS and
mean internalisation.

Figure 4.10: Fluorescent images of 9LGS after incubation with 0-10%
LAGMO NPs for 24 hours. Presented in the first row, are hoechst stains
of a cell with at least one internalised NP and the second row presents its
corresponding DCF stain as a result of cleavage from each treatment.

is a significance increase during nucleus cleavage [92].
Cancer cells experience a four-phase transition in its division process. Often,
drugs, nanoparticles and other external factors can cause damage to a cell primarily through entrapment in one phase of its cell cycle. Although it isnt the only
cause of damage as previously shown in the fluorescent images, it is another piece to
the puzzle of the cell-to-NP interaction. Most importantly cell cycle arrest due to
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Figure 4.11: PI-Flow cytometry of 9LGS after 24 hours of incubation with
all doped nanoparticles at 50 µg/mL.

nanoparticle treatment must be understood as it will impact radiation dose enhancement, whereby cell cycle entrapment plays a major role in radiosensitivity and cell
response to radiation damage. Figure 4.11, indicates that all silver-doped LAGMO
NPs have caused an increase of cells in the S-phase of the cell cycle. This is the
phase responsible for synthesis of DNA and RNA in preparation for the proliferation
of a cell. Notably, potent cancer killers such as methotrexate are characteristically
used for their ability to halt cells in the S-phase where repair and reproduction
are synthesised at its highest rate [93, 94, 95]. This result is first evidence of the
NPs having a use outside of dose enhancement, which primarily has dominated the
direction of this thesis.
This data possibly provides some insight towards the impact of 10%-LAGMO
NPs on the cancer cell line. S-Phase cell cycle arrest reaches its’ highest value at
the highest silver doping, indicating that the NP may be acting in more ways than
one to cause damage to the cell. It appears as though the NPs are inducing enough
oxidative stress to kill the 9LGS, but cell death is assisted with a significant increase
in the amount cells unable to progress to the G2/M phase. This result will need to
be examined to a higher degree in order to understand the exact mechanisms taking
place.
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Normal Cell Line (MDCK) versus Cancer Cell
Line (9LGS)

The concept of improvement in the cancer industry relies heavily upon the standards that treatment to the cancer site incurs minimised damage to normal tissue
and maximised damage to cancer tissue. As there are already treatment strategies
in place that are founded upon this notion, research with the chance of future implementation in the cancer field must be diligent to consider impact on normal tissue.
Specifically, in the case of NPs, as they must be injected into the blood stream and
situate within a deep-seated brain tumour, it is essential they are compared against
a normal cell line. Although, it is relatively non-comparable to a clinical situation,
experiments on the MDCK cell line will provide an understanding and some insight into a nanoparticle, capable of inducing oxidative stress onto cancer cells, and
its’ interaction with normal (non-cancerous) cells. The following experiments will
target viability, toxicity, cell response and cell behaviour as they are treated with
0-10%-LAGMO NPs.

4.3.1

9LGS vs MDCK: How do they interact with NPs?

9LGS and MDCK both being vastly different cell lines, also exhibit different interaction patterns with its extracellular environment. This is evidenced in Figure
4.12 (b), where the MDCK cells appear to have grown normally to confluence almost with no dead or dying cells, compared to the non-confluent 9LGS. The lack of
confluence on the cancer cell line indicates that the NPs hinder its’ ability to grow
drastically. Toxicity aside, the MDCK cells seem to cause the NPs to aggregate in
areas where cells are tightly networked. Furthermore, the distribution of LAGMO
nanoparticles are homogenously distributed as they become entangled between the
individual cells in (b). On the other hand, the NPs appear to have a strong affinity
to aggregate directly on and around the cancer cell line but are barely inside any of
the cells, illustrating that a much larger proportion of NPs stay outside MDCK cells
than 9LGS. The NP interaction with MDCK cells is extremely positive as they do
not appear to show signs of damaging behaviour on the healthy cells. Moreover, it
possibly indicates that the interaction with radiation and NPs to 9LGS will have a
much more adverse effect than they will for MDCK. This is due to the linear energy
transfer (LET) of secondary electrons produced outside of the cell, due to the lack of
internalisation by MDCK, being too low to cause sufficient damage the DNA inside
its nucleus.
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(b) MDCK

Figure 4.12: The interaction and distribution patterns witnessed with (a)
9LGS and (b) MDCK after incubation with 0%-LAGMO at 50 µg/mL for 24
hours.

4.3.2

Direct effect of all (0-10)%-LAGMO NPs on MDCK
cells

As a preliminary indicator of toxicity, another MTT assay was performed for all
doped NPs (see Figure 4.13). Viability for MDCK after incubation with 0%, 2.5%
and 5%-LAGMO NPs are all above 100% at all concentrations, including 250 µg/mL,
however, 10% appears to be toxic at all concentrations. This indicates that there is
a large potential for selectivity with cancer cells over normal cells for LAGMO NPs
doped with less than 10% silver.
The concept of cell selectivity, however, must be challenged directly in order to
confirm such interactions will take place. For this reason, a co-culture experiment
was designed using the IncuCyte. It involved seeding both 9LGS and MDCK into
the same well at a confluence of 120 000 and 80 000, respectively, to account for
differences in cell sizes. The aim of the experiment was to visualise the effect of
having one cell of each cell line in the proximity of 0%-LAGMO NPs and witness how
they communicate. Hence, an image directly in the centre of the well was extracted
from the software at 24-hour intervals allowing cell processes to be tracked.
As expected, at 24 hours after incubation with the NPs there seems to be plenty
of death in the well and that death is mostly assigned to 9LGS cells (see Figure
4.14). Taking into account that MDCK does divide every 16 hours and may have
already died before the image at 24 hours incubation was taken, certain cell groups
have been tracked over the course of three more days in areas dense with NPs.
This is visible as the blue arrows point to MDCK cell groups and black arrows
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Figure 4.13: MTT viability assay of all doped LAGMO NPs incubated for
24 hours with MDCK.

point to 9LGS cell groups. Tracking the movement of the marked MDCK cells
over the course of the next three days at 24-hour intervals highlights migration
and unaffected growth. On the other hand, for 9LGS, the groups of cells pointed
out in (a) are unable to recover and all other surrounding cancer cells begin to
become heavily affected. These ground-breaking results elucidate the possibility
that Lanthanum Manganite nanoparticles will act in a selective manner when used
for treatment alongside radiation. Due to the time constraints, IncuCyte studies of
2.5% and 5%-LAGMO NPs incubated with co-cultures were unable to be obtained.
It is hypothesised that both aforementioned NPs are cancer cell selective due to
the previous MTT, however, it would be of great interest to perform a co-culture
experiment.
Survival over extended periods of incubation with the NPs is an important
parameter that must be considered as the NPs may not have an immediate toxic
effect on the MDCK cell line. This was the case with previously shown 0%-LAGMO
NPs, which presented over 100% viability at 50 µg/mL at 24 hours but deteriorated
at 74 hours. Nevertheless, it was expected that 2.5% and 5%-LAGMO NPs would
be non-toxic in comparison to 10% silver doped NPs.
Presented above the Incucyte images in Figure 4.15 (a) is a graph which provides
a confluence percentage based off how much surface area is covered with cell-like
structures. The IncuCyte software also outputs its own error data based off the
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(a) 24 Hours

(b) 48 Hours

(c) 72 Hours

(d) 96 Hours

Figure 4.14: IncuCyte images of co-cultured 9LGS & MDCK to visualise
cell death and growth while incubated with 0%-LAGMO NPs at 50 µg/mL.

standard error present between different sectors of a well. The images presented
are very significant in that it confirms the safe co-existence between 0%, 2.5% and
5%-LAGMO NPs and MDCK (healthy) cells with no indication of delayed toxicity.
The growth, though confluent, appears to be hindered in the sense that the MDCK
struggles to grow at the same exponential rate present in the control (no NPs). The
hinderance can be attributed to the territorial nature of cell lines such as MDCK,
which grows in a way to leave no space between each individual cell. Consequently,
as cells begin to proliferate over many days, MDCK eventually forms central points
of dense cell regions as they prefer to divide towards the closest corresponding cell.
This type of cell behaviour can be confirmed by noticing the naturally induced
apoptotic cells that become prevalent in the centre of the densest areas of the well.
It should be noted that almost all PI emissions in their respective wells are a direct
result of limited space for the cells to proliferate.
Conversely, the ill-fated obliteration of the MDCK cells when treated with 10%LAGMO NPs creates a certain level of uncertainty with its pathways to death.
With previous knowledge of all NPs inducing toxic levels of reactive oxygen species
to 9LGS it would appear that MDCK can overcome these levels. Notably, MDCK
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(a) Confluence graph of all treatments

(b) 0%-LAGMO

(c) 2.5%-LAGMO

(d) 5%-LAGMO

(e) 10%-LAGMO

Figure 4.15: Incucyte images showing the confluence of MDCK cells as a
result of 24 hour incubation with 0-10%-LAGMO at 50 µg/mL.

cells characteristically have higher levels of ROS than the general cell line and can
also withstand significant levels of ROS induction to a certain extent. This effect
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may be the underlying reason as to why the NPs have a selective non-toxic response
to silver-doped Lanthanum Manganite until above a threshold of 5% silver dopant.
In order to gain a greater understanding as to why 10%-LAGMO NPs are the
only toxic NP to the MDCK cell line, visual impact on cell structure including
membrane integrity and nucleus must be examined. Seeing as though 10%-LAGMO
NPs are ROS producers, fluorescent images were taken in order to visualise whether
the same effects occurring in 9LGS are also present in MDCK.

(a) MDCK

(b) 9LGS

Figure 4.16: Fluorescent images of (a) MDCK and (b) 9LGS cells after
incubation with 50 µg/mL of 10%-LAGMO NPs for 24 hours. Cell death
indicators are zoomed in and labelled with death type.

Cells, as mentioned throughout this thesis, have specific pathways that are triggered within the cytoplasm, inducing eventual apoptosis. Apoptosis, the most common form of death, predominantly occurs due to damage incurred on the cell which
has triggered this response. This can be seen in Figure 4.16, where 9LGS experiences
various forms of damage. The most common forms of death visualised in (b) are
apoptosis and also lysis (rupturing of the cell membrane). It’s clear in the apoptotic
cells that ROS levels are extremely high with bright fluorescence, however, this is
not the case for ruptured membranes. This is most likely due to ROS triggering
pathways that lead to the rupturing of the membrane and consequently leaking the
ROS into the media. The last form of death witnessed on cell lines, is a newly coined
term, and is referred to as anoikis. This is attributed to cells that detach themselves
from the surface of the extracellular matrix as a form of programmed cell death
(apoptosis). Notably, this type of cell death has heightened levels of ROS and can
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be seen in both cell lines, and with 0%-LAGMO NP affected cells. It can definitely
be concluded that 9LGS is heavily affected by the presence and internalisation of
NPs, causing increased ROS levels and eventual programmed cell death through
multiple pathways.
Conversely, the MDCK cell line exposed to the same treatment of NPs, shows an
average amount of ROS throughout the whole image. There are no visual indicators
of heightened levels of ROS except for peeling cells. There are many reasons that
can explain this type of behaviour. For instance, it’s clear in 9LGS that there is a
cleavage of the nucleus for all four investigated NPs, where the cleavage was a direct
response to DNA damage from free radicals and ROS. The same cleavage is present
in many cells towards the centre of the image, with likelihood that it is related to
ROS production. Since the cleaved cells do not visually show high amounts of ROS,
it is hypothesised that the mechanisms responsible for the cleavage are acting at an
extremely fast rate. In addition to cleavage, anoikis is visible in some MDCK cells
that are surrounded by or in close proximity to the NPs. Therefore, it is highly
likely that the cell killing effect of 10%-LAGMO NPs is a direct result of increased
ROS levels. Figure 4.16 (a) also suggests that the pathway to cell death occurs at a
fast rate, explaining why no apoptotic cells are present 24 hours after the cells are
exposed to treatment.
With induced oxidative stress having a strong correlation to nucleus cleavage of
cells and also silver ions presenting this risk, a time course experiment of the total
ROS levels was performed.
The time course provides an insight to the cells’ interaction with the NP (see
Figure 4.17). It appears as though the NP is acting at an alarmingly high rate,
where total ROS increased massively after 7 hours incubation. This solidifies the
argument that 10%-LAGMO NPs will act in a way to kill MDCK cells through
heightened levels of ROS and further substantiates the image seen in Figure 4.16
(a). All investigated NPs cause the cells to experience up to three times the total
level of ROS than presented in the control. This is not a surprise as MDCK, being a
healthy cell line, is able to withstand higher levels of ROS. It is extremely important
to point out the levels of mean internalisation amongst all nanoparticles are very
similar. This suggests that the toxicity to the MDCK cell line is not internalisation
dependant but wholly due to chemistry when doping Lanthanum Manganite with
10% silver. These results are very interesting and definitely adds to the degree
of ambiguity presented by 10%-LAGMO NPs. The NP in general requires further
study to perhaps divulge what type of surface chemistry is causing these high levels
of ROS.
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(a) 7 hours with NPs

(b) 13 hours with NPs

(c) 24 hours with NPs
Figure 4.17: A time course of the mean internalisation and total ROS of
MDCK after incubation with 50 µg/mL of 10%-LAGMO NPs for (a) 7 hours,
(b) 13 hours and (c) 24 hours. The data is normalised to the control (No
NPs) MDCK cells.

4.4

Radiation Dose Enhancement of 0%-LAGMO
NPs on 9LGS

4.4.1

Nanoparticle for Radiation Dose Enhancement: A comparison

An important aim of this thesis is to achieve dose enhancement with a nanoparticle in order to target the brain cancer cell line 9LGS. Therefore, it is imperative
that the NP that is focused on has optimal effects when it comes to toxicity level,
ROS production and internalisation. Comparing the different NPs and how each
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interact with cells individually make the decision much easier. 0%-LAGMO NPs
are toxic to some degree, but this effect for the most part, is present after 24 hours
as seen in IncuCyte and MTT results. Additionally, it produces the least and significantly lower amounts of ROS within each cell in comparison to the other doped
NPs for 9LGS. Another beneficial quality is cancer cell selectivity, providing no toxicity to MDCK healthy cells and relatively low levels of increased ROS compared
to un-treated MDCK. It will be very important to understand the radiation dose
enhancement as a result of the 2.5% & 5%-LAGMO NPs as they are also selective,
however, are unable to be investigated in this thesis due to time constraints.

4.4.2

Improving the effect of radiation on 9LGS using 0%LAGMO NPs

In the lead up to the radiation experiment, cells were acclimated to reach confluence
after five days of growth in order to raise the general plating efficiency of un-treated
9LGS. This aids the predictability of cell growth when they are seeded into plates
and also increases the likelihood of lower-seeded plates to grow enough colonies.
Addition of NPs to the T-12.5 cm2 flasks took place exactly 24 hours prior to
irradiation with 125 kVp orthovoltage x-rays ranging from 0-8 Gy. It should also
be noted that previous experimental results involved addition of NPs to T-25 cm2
flasks via different volumetric calculations. In the case of all radiation experiments,
250 µg of NPs were added to T-12.5 cm2 flasks containing 5 mL of media, equating
to 50 µg/mL.
The cells treated with nanoparticles prior to irradiation are wiped out, as plates
seeded from treated flasks at all doses provided under 25 colonies and thus were statistically insignificant (see Figure 4.18). This is also the case for nanoparticle flasks
unexposed to radiation, which was expected to have approximately 37% surviving
fraction (SF) as previously shown in the cytotoxicity assay. The plating efficiency
(PE) of untreated 9LGS after exposure to 0 Gy radiation was 7.53 ± 1.35%, however, the NP treatment produced cells with a PE of 0.44 ± 0.03% at the same dose.
The reasoning behind this unexpected result may be attributed to the poor condition of the cells when they were seeded into their respective plates. Nevertheless,
a complete dose curve for 9LGS was successfully obtained in agreement with the
work presented by Stewart et. al. 2016 [96]. It is apparent that 50 µg/mL with 125
kVp radiation is extremely potent combination and quite possibly not necessary for
treatment to 9LGS. On the other hand, the nanoparticle may also be viewed as an
ideal dose enhancer capable of wiping out enough of the cells to incapacitate their
growth. Nonetheless, both conclusions will require further investigation.
Further analysis into the radiobiological effect that the cells experience neces-
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Figure 4.18: 9LGS surviving fraction after treatment with 125 kVp orthovoltage radiation.

sitates a visualisation of cell health. This was best done with the IncuCyte as
it successfully provided insight on cell behaviour in response to outside sources of
toxicity. Cell experiments involving both radiation and IncuCyte were designed in
a way to distinguish two extremities of cell death; low dose (2 Gy) nanoparticle
toxicity with radiation and high dose (8 Gy) nanoparticle growth hinderance with
radiation. Similar to the clonogenic assay, T12.5 cm2 were either pre-treated with
nanoparticles or left un-treated, which will allow for a ’growth hinderance’ result
to be extrapolated. Furthermore, the concentration of NPs that was used for this
experiment was 20 µg/mL to ensure that both the effect of toxicity and high-Z dose
enhancement may be visualised and assessed. Extra care and close supervision of
the cells was imperative due to the unknown nature of the cell destruction witnessed
in the clonogenic assay results.
Concerning the control, the confluence of each dose is almost identical to the
surviving fraction which was witnessed in the clonogenic assay. This acts as confirmation for both the healthy condition of cells prior to treatment and the trustworthiness of using IncuCyte confluence data to understand growth outside of colony
growth analysis. Presented in Figure 4.19 (c) & (d) are graphs of the percentage of
cells with PI (PI-cells), which rely on the assumption that cells that are damaged
or dying will correspond to one PI event. Interestingly, after approximately one
doubling time there is a small peak in the number of cells that are getting stained

(d) 9LGS-NP’s: Cells with PI

(c) 9LGS-Control: Cells with PI

Figure 4.19: Confluence of (a) control-cell and (b) nanoparticle-cell seeded plates. Below each confluence graph is (c) cells with PI in
the control and (d) cells with PI in the nanoparticle plate. Both flasks (with and without NP 20 µg/mL treatment) are seeded into a
24-well plate after irradated with 125 kVp x-rays at 0, 2 & 8 Gy

(b) 9LGS-NP’s: Confluence

(a) 9LGS-Control (No NP’s): Confluence
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with PI for all doses, however, this appears to be the point where the 8 Gy treated
cells separate from the 0 Gy and 2 Gy trends. This reveals that a considerably
larger proportion of cells, as a response to 8 Gy radiation, will be unable to recover
after treatment. Additionally, these cells are only able to continue growth after the
PI-cell percentage significantly drops. This is very telling of the growth patterns of
9LGS in response to high dose radiation, indicating that PI-cells (damaged cells)
will not recover and eventually experience apoptosis.
The control confluence and PI-cell data will be used as a reliable juxtaposition
to the nanoparticle-affected cell confluence and PI-cell data. Note that it is assured,
the plate resulting from the nanoparticle-affected flask in this instance does not add
any confluence to the well as the NPs are removed in the wash step when seeding
into the plate. The growth of 9LGS cells after treated with non-irradiated undoped
lanthanum manganite nanoparticles is severely hindered with a confluence of 21%
(see Figure 4.19). Using the control PI-cell data as a comparison, the doses should
have a severe characteristic impact at approximately 40 hours after seeding. This,
however, is not the case as we are witnessing almost ten times the number of PIcells (≈18%) in half the time (20 hours). This can be attributed to the nanoparticle
toxicity, since seeding does not exclude damaged cells. Moreover, the actual effect of
high-dose treatment becomes prominent roughly 70 hours after seeding. Similar to
the control, this may be a direct result of the cells natural mitotic process and affects
their ability to divide, especially at high doses. It then becomes clear that 70 hours
after treatment, the 0 Gy and 2 Gy cell groups are able to repair the mechanisms
driving it towards death and suddenly begin to grow. This is characteristic of
9LGS, being that it has superseding radiation repair and resistivity characteristics
over other cell lines. Further visual analysis of the confluence graphs highlights
the drastic lag in growth and doubling time for both 0 and 2 Gy affected cells.
Cells treated with the nanoparticles followed by 2 Gy, observably grow to a similar
confluence to the 0 Gy treated cells, most likely due to limited time frame in which
the confluence was recorded. Had the growth been monitored more than 7 days,
we might have noticed a variation in confluence between the two doses. The PI-cell
percentage at 2 Gy, also appears to increase in comparison to 0 Gy at 182 hours.
The confluence percentages presented by the ZOOM software, were then extracted at each time the plate was imaged and analysed. From this information, the
doubling time of the cells can be directly calculated in order to show how radiation
alone, NPs alone and NPs combined with radiation affect the cells’ ability to divide.
As mentioned previously, 9LGS will always divide approximately every 35-37 hours,
the change in this value as a result of the treatments can be seen in Figure 4.20.
Upon visual analysis of the two treatment regimens and the resulting doubling
time, it is evident that cells pre-treated with lanthanum manganite have a doubling
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Figure 4.20: Doubling time of 9LGS cells after 0, 2 and 8 Gy radiation
treatment on cells alone and cells incubated with 20 µg/mL of 0%-LAGMO
NPs 24 hours prior.

time almost twice as long. Furthermore, the PI-cell trends witnessed in Figure 4.17
(c) & (d) directly correlate to their corresponding doubling time when not exposed
to radiation. Therefore, all cells pre-treated with NPs will have a 66-hour doubling
time but alongside radiation, depending on the dose, that number can be increased
significantly. We can confirm the statement that at 2 Gy, growth is stunted slightly
but still able to recover, whereas 8 Gy treated cells in both the control and NP cells
are unable to recover when it became time to proliferate.

Figure 4.21: Growth hinderance ratio of 9LGS cells treated with 0%LAGMO (20 µg/mL) incubated 24 hours prior to 125 kVp radiation.

Interestingly the lower doses for both plates have approximately the same GHR
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and this is likely due to the NP internalisation and distribution (see Figure 4.21).
The consequence of having large nanoparticles (up to 1 µm) alongside radiation
is that internalisation is reduced and the distribution throughout the flask is less
homogenous. Additionally, the low concentration of NPs drastically reduces the
number of secondary electrons produced as a result of the imparting x-rays. Notably,
at 8Gy, there are far more x-rays and secondary electrons produced, however, the
high levels of ROS that are potentially produced from both the NP and the radiation
seemingly annihilate the cancer cells. It has already been proven that the toxicity of
the nanoparticles directly affects the nucleus and therefore, combined with radiation
amplify this effect through the radiations’ ability to create double strand breaks in
the DNA of the nucleus. These are very significant results, indicating that not
only will the nanoparticles hinder the growth majorly at low doses, but it also
harnesses the power to destroy the cancer cells’ repairability and resistivity to high
dose radiation. It also claims that for low dose radiation it is necessary to use
concentrations of 0%-LAGMO NPs higher than 20 µg/mL.

4.4.3

Elucidating the cancer selectivity of undoped Lanthanum Manganite

Substantiating the cancer selectivity ability of 0%-LAGMO nanoparticles over healthy
cells when exposed to radiation is essential when providing evidence for its use in
further dose enhancement studies. For this reason the same radiation-IncuCyte experiment was set up in order to confirm that the MDCK cells will not experience a
hinderance in growth as a result of the undoped Lanthanum Manganite nanoparticles.
Surprisingly, it seems as though the nanoparticles have boosted the growth of
MDCK and achieve higher confluence percentages at each dose. The low confluence
of MDCK alone, without nanoparticle pre-treatment for 2 Gy and 8 Gy, is expected
since it is a healthy cell line and essentially has minimised resistivity to radiation
(see Figure 4.22). The increase in confluence for the case with nanoparticles is
likely due to the condition of the cells before seeding into the wells. MDCK, as
mentioned previously, opts to grow attached to neighbouring cells and since they
have a relatively short doubling time, the density added to the well is extremely
small. This meant that virtually all growth inside the plate occurred from only
a single cell over the course of the experiment, thus further emphasising on the
extraordinary ability for the MDCK cell line to grow after exposure to 0%-LAGMO
NP’s.
Combining the data retrieved from both experiments provides remarkable results, further pushing the idea of the selective ability for 0%-LAGMO NPs (see
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Figure 4.22: Confluence of MDCK after it was irradiated with 125 kVp
orthvoltage x-rays at 0, 2 & 8 Gy. Cells, excluding the control, were incubated
with 20 µg/mL of 0%-LAGMO NPs 24 hours prior to radiation treatment.

Figure 4.23: Comparing confluence of 9LGS and MDCK after they were
irradiated with 125 kVp orthovoltage x-rays at 0, 2 & 8) Gy. Cells, excluding
the control, were incubated with 20 µg/mL of 0%-LAGMO NPs 24 hours
prior to radiation treatment.

Figure 4.23). The difference in growth capabilities of each cell line becomes very
prominent at all doses. It becomes quite clear that undoped Lanthanum Manganite
does acquire a propensity to affect the brain cancer cell line while providing almost
no toxicity to the healthy cell line. Therefore, from this information we can suggest that 0%-LAGMO nanoparticles, will incur little to no damage to healthy cells
when used alongside radiation treatment of cancer. More importantly, however,
are that the NPs appear to protect the healthy cells from the damaging effect of
the radiation. This leaves room to investigate in a further study, whether the NPs
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are actually preventing damage from both radiation and NP produced ROS in a
scavenging manner.

4.4.4

Re-assessment of Radiation Dose Enhancement due to
undoped Lanthanum Manganite

The new findings of growth behaviour for 9LGS provides ease when understanding
how the cells will respond to both low dose and high dose radiation. Therefore,
another clonogenic assay was set-up for 2 Gy with adjusted seeding densities taking
into account for the extremity of damage. The cells were not treated with 8 Gy,
since it is expected they will have little-to-no capacity to grow colonies at this high
dosage.

Figure 4.24: Clonogenic Assay of 9LGS after it was irradiated with 125
kVp orthovoltage x-rays at 0 and 2 Gy. Cells, excluding the control, were
incubated with 50 µg/mL NPs 24 hours prior to radiation treatment.

The results in Figure 4.24 displays almost total cell death in both doses illustrating its severe toxicity to 9LGS. This suggests that using these nanoparticles may be
extremely toxic without radiation, based off its ability to increase ROS production
within the cell. After receiving 2 Gy radiation, colony growth for cells pre-treated
with NPs could only be seen at the highest seeding density of 125 000 individual
cells compared to the control (no NPs), which only needed 1900 individual cells.
This indicates that the chemistry involved in the combinational therapy may be the
form of toxicity overpowering radiation damage.

Chapter 5
Discussion
Substantiating the usage of a nanoparticle for radiation dose enhancement purposes
requires a complete characterisation of its interactions, toxicity and overall effect
on cancer cells. In the case of Lanthanum Manganite, it was expected that it can
provide this dose enhancement, as it is a high-Z material capable of increasing the
production of secondary electrons upon interaction with radiation. However, with
no prior knowledge on how these NPs interact with 9LGS, it was unclear on how
beneficial enhancing the radiation dose may be.
With no known studies on both healthy and cancer cell lines, it was hypothesised that the toxicity attributed to undoped Lanthanum Manganite, if any, would
increase when silver ions were added to their structure. Therefore, justifying the
major focus positioned on toxicity taking place at the microscopic scale. The viability of 9LGS after being treated with undoped nanoparticles showed signs of toxicity
at higher concentrations (above 100 µg/mL) for 24 hours incubation with the cells
and at all concentrations when incubated for 72 hours. Most importantly, the cells
presented (100 ± 15)% viability at 50 µg/mL for 0%-LAGMO NPs, while this figure
dropped by up to 40% for all other doped nanoparticles.
On the other hand, MDCK cells experienced absolutely no reduction in viability when treated with all doped nanoparticles, excluding 10%-LAGMOs. Moreover,
a boosting of viability for the non-toxic NPs was witnessed as the nanoparticle
concentration had increased. The exact reasoning behind a toxicity due to the 10%LAGMO NPs is still unclear, however, it may have a direct correlation to their
distribution and average size. Strikingly, the non-toxic response of MDCK to (0, 2.5
& 5)%-LAGMO NPs correlates directly to their characteristic resistance to internalising NPs. Due to the fact that four individual nanoparticles were investigated, and
must be explored as completely unique to each other, it was difficult to specifically
target 10% silver doping for this study. Further investigation into this could quite
possibly reveal some interesting characteristics about the NP.
The viability presented in all nanoparticles for 9LGS was not completely indica64
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tive of their effect on the cell line. A visual breakdown of the condition of the cells
revealed that not only were high levels of free radicals causing the toxicity but also
that there were many structural indicators of pre-apoptosis. Pre-apoptotic condition of the cells is particularly desirable when it is not exceedingly witnessed on a
population.
In the case of 10%-LAGMO NPs incubated with MDCK cells, the only damage
that was visible included anoikis and lysis, the latter of which, nucleus was clearly
cleaved. The average ROS of each cell in the population was relatively normal in
comparison to the control after 24 hours. Additionally, apoptosis was not witnessed
in any cells. This is most likely due to the cells doubling time, which is 16 hours,
and therefore MDCK cells may have struggled with the internalisation of the NPs
and thus are unable to divide. This would result in the cells triggering death much
faster than witnessed in the cancer cell line. This was later confirmed through an
analysis on the total ROS of a population of 20 000 cells, which found that after
7 hours it was 7 times that of the control. It will be worth investigating whether
the NPs start to scavenge the ROS produced after 7 hours, which would imply it is
functioning in a more protective manner. Again, 10%-LAGMO NPs was the outlier
compared to all other nanoparticles and is acting in a certain way, when internalised,
to kill high ROS-tolerant cells such as MDCK. Perhaps, a better way to assess the
NPs toxicity would be through using reactive oxygen species assays that specifically
identify, which species is produced and exactly how much of each is being produced.
A recurring issue related to the imaging process involves the extreme difficulty in
attaining images that involve excitation of DCF. Its tendency to photobleach after
exposure to its excitation wavelength was amplified using the same molar concentrations for culture materials with less surface area. Visual analysis, should therefore
only be used as a guide, or visual confirmation of undisputed total population ROS
increase or cell death.
Cancer cell selectivity was challenged directly through co-culturing and was
true for all NP’s except for 10% LAGMO NPs. For all other NPs, 9LGS, when
grown alongside MDCK cells, was completely killed while leaving the healthy cells
unaffected. The behaviour of MDCK growth also caused the 9LGS and NPs to be
both pushed into regions of empty space where they are forced to interact with each
other. Therefore, the response to NPs amongst both cell lines caused a ’killing-off’
effect to the cancer. This pushes the boundaries of possibilities for this nanoparticle
far beyond radiation dose enhancement, as cancer selectivity is unique to very few
NPs and beneficial in many strategies that target cancer.
Further analysis into 9LGS cell response to all nanoparticles divulged that the
cells were in fact being held in the S-phase of the cell cycle. More specifically, each
dopant (0, 2.5, 5 & 10)% arrested 18.3%, 15.6%, 17.5% and 19.4% respectively. This
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could perhaps provide further insight as to why the 10%-LAGMO nanoparticles were
not generating as much total ROS across a population in comparison to the other
doped NPs. Further investigation into this will be very important in understanding
the mechanism of this NP inside cancer cells. It may also be very beneficial to see
the cell-cycle analysis of the NPs on MDCK and further substantiate the concept
of cancer cell selectivity.
As a clear front-runner for use alongside radiation, a relatively low concentration
(20 µg/mL) of 0%-LAGMO NPs was investigated with radiation for both cell lines.
9LGS confluence at each dose (0,2 & 8) Gy was (21.3 ± 8.2)%, (23.5 ± 5.4)%
and (0.8 ± 1.0)% respectively. Whereas MDCK, seemingly had a boosted growth
compared to its own control, with values (92.8 ± 14.1)%, (56 ± 4.7)% and (2.8
± 1.1)%. The ability for the MDCK cells treated with nanoparticles to outgrow
those that were not treated, is quite telling of how prevalent the non-toxic response
is. It suggests that the NPs act in way to protect the cells, perhaps through a
scavenging effect. Due to time constraints, a confluence analysis after the treatment
of the doped-nanoparticles, 2.5% and 5%-LAGMO was unattainable. Indeed, an
investigation into these NPs will be very important as all results indicate a similarly
beneficial response as 0%-LAGMO NPs. It will be very advantageous to quantify
growth patterns and response to each cell line for consideration of future treatment
techniques other than radiation dose enhancement.
Most importantly, however, was the result achieved after low dose radiation
treated 9LGS cancer cell line after incubation with 0%-LAGMO NPs for 24 hours
at 50 µg/mL. This ultimately resulted in a catastrophic surviving fraction (SF)
of (3.7 ± 11.5)% at 0 Gy and (0.6 ± 6.7)% at 2 Gy. The large error in these
values is a testament to the degree of damage that the cells experience before the
plating procedure is conducted. Even though all plates were counted, however, the
cells ability to recover at each dosage is severely hindered. This significant result
suggests that the NP has a more chemical effect on the cell line rather than a direct
result of dose enhancement.
Comparing the 0 Gy NP treatment SF in the cytotoxicity assay and a clonogenic
assay presents conflicting results. This may be directly correlated to the difference
in NP addition methods attributed to each experiment. The technique used in the
cytotoxic assay with T-25 cm2 flasks includes a volumetric calculation of nanoparticle
concentration, which differs to the technique used for the T-12.5 cm2 flasks in a
clonogenic assay. Achieving a 50 µg/mL concentration for the clonogenic assay
involved the addition of 250 µg of NPs as it takes into account a large volume of 5
mL. Comparing the two NP addition techniques by surface area coverage, as the NPs
are expected to all sink to the bottom flask, shows that the clonogenic assay presents
4 µg/cm2 whereas the cytotoxicity assay presents 3.6 µg/cm2 . This discrepency can
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be eliminated by utilising one technique throughout each experiment in a further
study.
Overall, improvements to the experimental process of a clonogenic assay in the
future will include greater amounts of cells for seeding densities to obtain a more
precise result. Furthermore, it would also be beneficial to perform a clonogenic assay
on MDCK cells at low dose radiation in order to fully characterise the cancer cell
selectivity. Finally, it is clear that the undoped nanoparticle is extremely toxic to
cancer cell line 9LGS and must be improved for dose enhancement purposes.
The results indicate that LAGMO NPs have a great potential to be used in combination with various radiation therapy techniques. Accessibility of this nanoparticle
to tumour sites is plausible as it has been studied in vivo and therefore are able to
reach deep-seated tumours such as those found within the brain [13]. As this study
discovered that the NP is cancer cell selective and potentially boosts the growth of
healthy cells, it should also be considered for research on a wide range of tumours.
This study also shows that these NPs have a great potential to also be used for tumours that are treated with megavoltage radiation as they will provide considerably
higher levels of energy deposited to tumours while causing significant damage at the
cellular level.
Silver doped lanthanum manganite also displays the clear advantages of using
bimetallic NPs to combat the radioresistivity of cells such as glioblastoma. The advantages of using silver ions in the structure of lanthanum manganite NPs were clear
in showing that there is an increased toxicity. The literature had suggested that silver nanoparticles and an introduction of silver ions alone were toxic and the LAGMO
NPs utilised this to trigger larger amounts of reactive oxygen species. Bimetallic
nanoparticles deserve to be considered as potential bifunctional NPs alongside radiation therapy as studies may benefit when involved with radioresistant cell lines
that necessitate extra cell damage using complementary damage pathways.
Future study on the use of LAGMO NPs will possibly need to consider coating
the nanoparticles to allow greater abundance at the tumour site or considering them
as drug carriers as they appear to have non-toxic effect to the healthy cell line.
Another strategy that may be worth considering, is the investigation of free radical
scavengers that are able to protect cells’ exposure to reactive oxygen species, thereby
reducing toxicity to the cells.

Chapter 6
Conclusion
Introducing new nanoparticles to target radioresistant brain cancer cells, requires
an extensive study on the effect these nanoparticles have both with and without radiation. The potency attributed to the lanthanum manganite nanoparticles without
radiation treatment are quite telling of its potential to kill cancer. Consequently,
the nature of a cell line such as 9LGS and its tendency to invaginate relatively large
external objects such as these nanoparticles, also make it ideal for both radiation
treatment and toxicity. On the other hand, the MDCK cell line, displays a more
resistive effect, likely due to its unique growth behaviour and ability to disregard
extracellular nanoparticles.
A series of experiments, which involved viability, imaging and monitoring were
used in order to decide which nanoparticle would be optimal for dose enhancement.
This proved to be 0%-LAGMO NPs as they were the least toxic to the cancer cell
line while still exhibiting enough damage. The damage became most noticeable
after one day and therefore suggests that the nanoparticles have a delayed effect.
The toxicity, though, was extremely visible for higher doped nanoparticles. This is
perhaps a direct result of the silver ions present in the structure of the nanoparticles,
which are known to produce reactive oxygen species.
Most importantly, the concept of cancer selectivity with (0-5)%-LAGMO nanoparticles was elucidated, as the viability assays confirmed zero toxicity to MDCK cells.
10%-LAGMO NPs, however, was the only nanoparticle to cause significant toxicity
to the healthy cell line. The result of selectivity is extremely significant as it provides
great promise for the future investigation of the non-toxic nanoparticles beyond the
scope of this thesis.
Furthermore, all nanoparticles that were toxic to 9LGS cells, was causing this
toxicity most prominently through an increase in the oxidative stress to the whole
population. This effect was most visible on higher doping levels such as 2.5% and
5% silver-doped Lanthanum Manganite. The two NPs substantiated the theory
that the increase in doping did correlate to an increase in total ROS of 9LGS cell
68
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populations, however, not necessarily a total increase in toxicity across a population.
This is the case as the doped nanoparticles are visually killing the cells at a similar
rate. Alternatively, for MDCK, 10% LAGMO nanoparticles were the only NPs able
to produce significant levels of ROS. In all nanoparticles for 9LGS and only 10%LAGMO for MDCK, pre-apoptotic forms of death such as anoikis, lysis and nucleus
cleavage were all very visible. The aforementioned forms of death are linked to
higher levels of reactive oxygen species, thus confirming oxidative stress to be the
main reason behind the toxicity of these nanoparticles. The chemistry associated
with increased levels of free radicals inside a cell and its eventual death possibly
provide both beneficial or an overpowering effect alongside radiation.
Growth of 9LGS was severely hindered after pre-treatment with 0%-LAGMO
NPs two and a half times lower than the optimal concentration and then irradiated
with 125 kVp orthovoltage x-rays. The growth hinderance factor as a result of the
NPs on 9LGS was extremely prominent at higher dose 8 Gy, which in turn completely destroyed the cell lines’ ability to recover. Lower dose radiation, however, did
not stop the cancer cells from eventually recovering. This, as a result, necessitates
an increase in dose in order to target the cell line. The opposite effect was witnessed for MDCK cells, where they tended to be boosted slightly as a result of the
nanoparticles. The boosting of the MDCK is likely due to the nanoparticles inside
the flasks allowing the cells to be more confluent and this has a considerably positive
effect on their growth. Additionally, the NP on the healthy cell line may exhibit
a scavenging effect and ultimately protect the cell from the produced ROS. Most
importantly, the nanoparticle alongside the radiation highlighted the zero toxicity
to healthy cells as they were able to grow into large healthy colonies from mostly
single cell distributions.
Treating 9LGS with 50 µg/mL 0%-LAGMO nanoparticles prior to irradiation
was extremely damaging to the cell line. The cells required a significantly high seeding density into plates in order to form colonies once they were allowed to grow. It
is clear the chemical toxicity of the NPs is the most dominant when alongside radiation. The induction of oxidative stress mainly from the nanoparticles themselves
but also combined with the radiation emphasises the potency of this paticular treatment. Due to the cells lack of high levels of internalisation and the large aggregates
of NPs, dose enhancement didn’t seem to have a significant effect. At high doses,
this may become visible, however, the nanoparticle appears to be too toxic and will
seemingly obliterate the cells.
Overall, it was found that there was a cancer specific selectivity for 0, 2.5 and
5%-LAGMO nanoparticles, however, not for the 10% silver doped nanoparticles.
Further, the chemical reactions occurring within the cell are extremely overpowering over the potential for a radiation dose enhancement effect. For the un-doped
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Lanthanum Manganite, it would be imperative to continue to divulge the occurrances within the cell, perhaps through experiments such as γ-H2AX staining after
irradiation. It may also be useful to utilise this nanoparticle, similar to that of a
drug, capable of inducing significantly high levels of oxidative stress alongside low
dose radiation. Further study could also improve on the impact of the nanoparticle by either introducing a coating or introducing free radical scavengers into the
environment of the cell.

Appendix A
List of Abbreviations
Abbreviations

Meaning

0%-LAGMO

0% silver-doped Lanthanum Manganite (LaMnO3 )

2.5%-LAGMO

2.5% silver-doped Lanthanum Manganite (La0.975 Ag0.025 MnO3 )

5%-LAGMO

5% silver-doped Lanthanum Manganite (La0.95 Ag0.05 MnO3 )

10%-LAGMO

10% silver-doped Lanthanum Manganite (La0.9 Ag0.1 MnO3 )

9LGS

9L gliosarcoma (rat brain glioma cancer cell line)

A549

adenocarcinomic human alveolar basal epithelial cells

BBB

blood brain barrier

Ca

calcium

CO2

carbon dioxide

D

dose

DAPI

4’,6-diamidino-2-phenylindole

DCF

dihydrodichlorofluorescein diacetate

DMEM

Dulbecco’s modified eagle media

DMSO

dimethyl sulfoxide

DNA

deoxyribonucleic acid

DPBS

Dulbecco’s phosphate-buffered saline

DSB

double strand break

E

energy

Eef f

effective energy
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EGFR

epidermal growth factor receptor

Em

fluorescence emission maximum

EPR

enhanced permeability and retention

Ex

fluorescence excitation maximum

FACS

fluorescence-activated cell sorter

FITC

fluorescein isothiocyanate

FSC

forward scatter

FSC-A

forward scatter area

G0-phase

quiesent cell phase

G1-phase

gap1, checkpoint for damaged DNA

G2-phase

gap2, checkpoint for segregation of abdnormal chromosones

GBM

glioblastoma multiforme

GHR

growth hinderance ratio

H2 O2

hydrogen peroxide

HeLa

human cervical cancer cell line

HepG2

human liver cancer cell line

IC50

half maximal inhibitory concentration

IHMRI

Illawarra Health and Medical Research Institute

keV

kiloelectron volt

kV

kilovolt

kVp

kilovolt peak

La

lanthanum

LaMnO3

lanthanum manganite

La1−x Agx MnO3

silver-doped lanthanum manganite

LET

linear energy transfer

M-phase

mitosis phase

MCF-7

human breast cancer cell line

MDCK

Madin-Darby canine kidney cells

APPENDIX A. LIST OF ABBREVIATIONS

73

Mg

magnesium

Mn

manganese

MnO3

manganese(VI) oxide

MRI

magnetic resonance imaging

MTT

3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide

MV

megavolt

N

counts

NADPH

nicotinamide adenine dinucleotide phosphate

NO

nitric oxide

NPs

nanoparticles

NSF

nephrogenic systemic fibrosis

O

oxygen

O2 −

superoxide

OONO−

perioxinitrate

p53

tumour protein, regulates cell cycle

PE

plating efficiency

PI

propidium iodide

PI-cells

pi-stained damaged cells

RF

resonance frequency

RNA

ribonucleic acid

RNase

ribonuclease

ROS

reactive oxygen species

SF

surviving fraction

S-phase

synthesis phase

SPIONs

super-paramagnetic iron oxide nanoparticles

SSB

single strand break

SSC

side scatter

SSC-A

side scatter area
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TiAgO2

silver-doped titanium oxide

U373

human glioblastoma astrocytoma cancer cell line

Z

atomic number
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